Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionstructural constituent of skin epidermis

KRT1 KRT5 KRT6A KRT6B KRT75 KRT6C

1.48e-06431676GO:0030280
GeneOntologyMolecularFunctionATP-dependent activity

MYH4 TDRD9 MYO5B TMEM94 NLRP1 YTHDC2 SMC5 IQCA1L AACS SMARCA1 MACF1 ATP11A DNAH6 DHX29 ATP5F1C HELLS

5.98e-0561416716GO:0140657
GeneOntologyMolecularFunctionactin filament binding

MYH4 HIP1 IQGAP2 MYO5B FMNL3 VILL XIRP2 MACF1 FMNL1

1.28e-042271679GO:0051015
GeneOntologyMolecularFunctionphosphatidylinositol binding

HIP1 IQGAP2 DENND1C RPH3A EXOC8 ITPR2 VILL PIK3C2B SNX1 ARAP1

3.39e-0431616710GO:0035091
GeneOntologyMolecularFunctionATP hydrolysis activity

MYH4 TDRD9 MYO5B NLRP1 YTHDC2 SMC5 IQCA1L MACF1 ATP11A DNAH6 DHX29 ATP5F1C

3.48e-0444116712GO:0016887
GeneOntologyBiologicalProcessintermediate filament cytoskeleton organization

KRT1 KRT5 KRT6A KRT6B KRT75 KRT6C MACF1

1.60e-05991677GO:0045104
GeneOntologyBiologicalProcessintermediate filament-based process

KRT1 KRT5 KRT6A KRT6B KRT75 KRT6C MACF1

1.71e-051001677GO:0045103
GeneOntologyBiologicalProcessintermediate filament organization

KRT1 KRT5 KRT6A KRT6B KRT75 KRT6C

3.27e-05751676GO:0045109
GeneOntologyCellularComponentsupramolecular fiber

KRT1 KRT5 KRT6A MYH4 KRT6B IQGAP2 CEP162 CARMIL1 ACTG2 MAP10 DCTN1 EIF6 PGM5 KRT75 KRT6C XIRP2 AMOT TTLL11 SIMC1 SLMAP ASPM TRIM55 MACF1 DNAH6

2.29e-05117916724GO:0099512
GeneOntologyCellularComponentsupramolecular polymer

KRT1 KRT5 KRT6A MYH4 KRT6B IQGAP2 CEP162 CARMIL1 ACTG2 MAP10 DCTN1 EIF6 PGM5 KRT75 KRT6C XIRP2 AMOT TTLL11 SIMC1 SLMAP ASPM TRIM55 MACF1 DNAH6

2.56e-05118716724GO:0099081
GeneOntologyCellularComponentkeratin filament

KRT1 KRT5 KRT6A KRT6B KRT75 KRT6C

1.29e-04971676GO:0045095
GeneOntologyCellularComponentcell cortex

MPP1 HIP1 IQGAP2 MYO5B DCTN1 MELK AKAP12 EXOC8 ITPR2 MACF1 FMNL1

2.03e-0437116711GO:0005938
GeneOntologyCellularComponentcornified envelope

KRT1 KRT5 DSC1 DSC2 KRT75

2.28e-04691675GO:0001533
GeneOntologyCellularComponentpolymeric cytoskeletal fiber

KRT1 KRT5 KRT6A KRT6B IQGAP2 CEP162 CARMIL1 MAP10 DCTN1 EIF6 KRT75 KRT6C AMOT TTLL11 ASPM TRIM55 MACF1 DNAH6

3.18e-0489916718GO:0099513
GeneOntologyCellularComponentintermediate filament

KRT1 KRT5 KRT6A KRT6B EIF6 KRT75 KRT6C MACF1

4.93e-042271678GO:0005882
GeneOntologyCellularComponentactin cytoskeleton

FKBP15 MYH4 HIP1 IQGAP2 MYO5B CARMIL1 ACTG2 CIT PGM5 VILL XIRP2 AMOT MACF1

7.54e-0457616713GO:0015629
HumanPhenoPalmoplantar blistering

KRT1 KRT5 KRT6A KRT6B

4.71e-0611584HP:0007446
DomainARM-type_fold

SMG1 HIP1 USP24 RANBP6 HEATR1 TRRAP ITPR2 FMNL3 PPP2R1B THADA NCAPG IPO9 AP2B1 PIK3C2B ASPM FMNL1

3.73e-0833916016IPR016024
DomainKeratin_2_head

KRT1 KRT5 KRT6A KRT6B KRT75 KRT6C

4.26e-08241606IPR032444
DomainKeratin_2_head

KRT1 KRT5 KRT6A KRT6B KRT75 KRT6C

4.26e-08241606PF16208
DomainKeratin_II

KRT1 KRT5 KRT6A KRT6B KRT75 KRT6C

7.19e-08261606IPR003054
DomainIntermediate_filament_CS

KRT1 KRT5 KRT6A KRT6B KRT75 KRT6C

1.63e-05631606IPR018039
DomainFilament

KRT1 KRT5 KRT6A KRT6B KRT75 KRT6C

3.25e-05711606SM01391
DomainIF

KRT1 KRT5 KRT6A KRT6B KRT75 KRT6C

3.53e-05721606PS00226
DomainFilament

KRT1 KRT5 KRT6A KRT6B KRT75 KRT6C

3.81e-05731606PF00038
DomainIF

KRT1 KRT5 KRT6A KRT6B KRT75 KRT6C

4.80e-05761606IPR001664
DomainTUDOR

TDRD9 RNF17 AKAP1

2.10e-04141603PF00567
Domain-

SMG1 TRRAP PIK3C2B

3.18e-041616031.10.1070.11
DomainPI3Kc

SMG1 TRRAP PIK3C2B

3.18e-04161603SM00146
DomainHEAT_REPEAT

SMG1 RANBP6 HEATR1 PPP2R1B NCAPG

3.35e-04701605PS50077
DomainP-loop_NTPase

MPP1 MYH4 TDRD9 MYO5B MTHFD1L NLRP1 CARD10 YTHDC2 SMC5 ATL1 UCKL1 ASPM SMARCA1 GNA11 DNAH6 DHX29 AGAP2 HELLS

3.57e-0484816018IPR027417
DomainIQ

MYH4 IQGAP2 MYO5B UBE3B ASPM

3.58e-04711605PF00612
DomainPrefoldin

KRT1 HIP1 KRT75 AMOT SLMAP

3.82e-04721605IPR009053
DomainPI3_PI4_kinase

SMG1 TRRAP PIK3C2B

4.58e-04181603PF00454
DomainPI3_4_KINASE_1

SMG1 TRRAP PIK3C2B

4.58e-04181603PS00915
DomainPI3_4_KINASE_2

SMG1 TRRAP PIK3C2B

4.58e-04181603PS00916
DomainPI3/4_kinase_cat_dom

SMG1 TRRAP PIK3C2B

4.58e-04181603IPR000403
DomainHA2

TDRD9 YTHDC2 DHX29

4.58e-04181603SM00847
DomainPI3_4_KINASE_3

SMG1 TRRAP PIK3C2B

4.58e-04181603PS50290
DomainHA2

TDRD9 YTHDC2 DHX29

4.58e-04181603PF04408
DomainHelicase-assoc_dom

TDRD9 YTHDC2 DHX29

4.58e-04181603IPR007502
DomainARM-like

SMG1 RANBP6 HEATR1 TRRAP PPP2R1B NCAPG IPO9 AP2B1 ASPM

5.45e-042701609IPR011989
DomainIQ

MYH4 IQGAP2 MYO5B UBE3B ASPM

6.57e-04811605SM00015
Domain-

RANBP6 HEATR1 TRRAP PPP2R1B NCAPG IPO9 AP2B1 ASPM

6.68e-0422216081.25.10.10
DomainHEAT

RANBP6 HEATR1 PPP2R1B NCAPG

7.53e-04481604PF02985
DomainRho_GTPase_activation_prot

IQGAP2 ARHGAP45 PLXNA2 RASAL1 ARAP1

9.58e-04881605IPR008936
DomainTUDOR

TDRD9 RNF17 AKAP1

9.63e-04231603PS50304
DomainIQ_motif_EF-hand-BS

MYH4 IQGAP2 MYO5B UBE3B ASPM

1.06e-03901605IPR000048
DomainFAT

SMG1 TRRAP

1.07e-0361602PS51189
DomainFATC

SMG1 TRRAP

1.07e-0361602PS51190
DomainFATC_dom

SMG1 TRRAP

1.07e-0361602IPR003152
DomainPIK_FAT

SMG1 TRRAP

1.07e-0361602IPR014009
DomainFATC

SMG1 TRRAP

1.07e-0361602SM01343
DomainIQ

MYH4 IQGAP2 MYO5B UBE3B ASPM

1.23e-03931605PS50096
DomainDesmosomal_cadherin

DSC1 DSC2

1.49e-0371602IPR009122
DomainCadherin_pro

DSC1 DSC2

1.49e-0371602PF08758
DomainHEAT

RANBP6 HEATR1 PPP2R1B NCAPG

1.54e-03581604IPR000357
DomainTUDOR

TDRD9 RNF17 AKAP1

1.55e-03271603SM00333
PathwayREACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE

KRT1 KRT5 KRT6A KRT6B DSC1 DSC2 KRT75

1.18e-05871257MM15351
PathwayREACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE

KRT1 KRT5 KRT6A KRT6B DSC1 DSC2 KRT75 KRT6C

1.90e-051291258M27649
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

KRT1 SMG1 KRT5 KRT6A MYH4 EME1 KRT6B AHCYL1 HK1 IQGAP2 MYO5B SLC44A2 ACTG2 HEATR1 RNF17 DCTN1 MEN1 PARP1 KRT75 KRT6C AP2B1 VAMP1 ASPM SMARCA1 MACF1 ATP11A DNAH6 PLXNA2 AGAP2 ZNF292 ATP5F1C

3.05e-1214421693135575683
Pubmed

Defining the membrane proteome of NK cells.

MPP1 KRT1 FKBP15 KRT5 KRT6A AARS1 FMR1 MTHFD1L ANXA7 DARS1 HEATR1 DCTN1 CIT MELK EXOC8 ITPR2 PARP1 NCAPG IPO9 PTPRC AP2B1 ATP11A AKAP1 ARHGAP45 MVP FMNL1 AGAP2 ATP5F1C

3.12e-1211681692819946888
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

KRT1 KRT5 KRT6A KRT6B AHCYL1 HK1 FMR1 IQGAP2 MYO5B ARGLU1 CARMIL1 DARS1 YTHDC2 BCAN DCTN1 CIT RPH3A ITPR2 PARP1 UBE2O AP2B1 AMOT MACF1 DNAH6 DHX29 UTRN RASAL1 AGAP2 ATP5F1C

6.86e-1114311692937142655
Pubmed

Defining the human deubiquitinating enzyme interaction landscape.

CCDC14 MYH4 LAMB4 AHCYL1 DSC1 MTHFD1L YTHDC2 NIBAN2 TRRAP MELK USP19 EXOC8 PARP1 PPP2R1B UBE2O IPO9 AP2B1 AMOT PIP SLMAP VSIG8 SCLT1 AKAP1 UTRN

1.41e-1010051692419615732
Pubmed

Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.

ARGLU1 USP24 CARD10 YTHDC2 NIBAN2 CHEK1 RNF17 DCTN1 MELK PARP1 PPP2R1B BRD8 NCAPG IPO9 MACF1 MVP ARAP1 HELLS

6.10e-105821691820467437
Pubmed

Charting the molecular network of the drug target Bcr-Abl.

KRT1 KRT5 KRT6A KRT6B DSC1 DARS1 KRT75 KRT6C AP2B1 PIK3C2B VSIG8 ARAP1 SOS1

7.27e-102661691319380743
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

FKBP15 AARS1 DSC1 CARMIL1 DARS1 YTHDC2 TACC2 NIBAN2 HEATR1 DCTN1 EIF6 AKAP12 PARP1 UBE2O AP2B1 MACF1 AKAP1 DHX29 UTRN SNX1 PML HELLS

1.14e-099341692233916271
Pubmed

Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.

PRPSAP1 KRT1 KRT5 KRT6A KRT6B AARS1 MTHFD1L CARMIL1 USP24 DARS1 TSN TACC2 PPWD1 DCTN1 EIF6 CIRBP PARP1 UBE2O NCAPG KRT75 KRT6C AP2B1 AGL MACF1 SNX1 ATP5F1C HELLS

1.25e-0914151692728515276
Pubmed

Inhibition of calpain 1 restores plasma membrane stability to pharmacologically rescued Phe508del-CFTR variant.

KRT1 KRT5 KRT6A KRT6B HIP1 DSC1 ARGLU1 ACTG2 DARS1 PARP1 PPP2R1B KRT75 KRT6C AP2B1 PIP MACF1

2.52e-094881691631324722
Pubmed

Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.

MAGEA4 AARS1 HIP1 HK1 DSC1 MTHFD1L RRM2B ANXA7 DARS1 NIBAN2 DCTN1 USP19 AKAP12 PARP1 PPP2R1B UBE2O NCAPG IPO9 AGL GNA11 VSIG8 MVP DHX29 UTRN SNX1 TPD52L2

2.81e-0913671692632687490
Pubmed

A high-throughput approach for measuring temporal changes in the interactome.

PRPSAP1 AARS1 AHCYL1 HK1 USP24 RANBP6 DARS1 TSN RO60 QRICH1 NIBAN2 EIF6 USP19 AKAP12 PPP2R1B UBE2O NCAPG IPO9 PPP4C AP2B1 AGL MACF1 MVP SNX1 RASAL1 TPD52L2

1.01e-0814551692622863883
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

MAGEA4 KRT6B AARS1 AHCYL1 HK1 DSC1 MTHFD1L DARS1 HEATR1 DCTN1 TRRAP MELK EIF6 PARP1 NCAPG IPO9 AP2B1 PIP ASPM SMARCA1 MACF1 MVP DHX29 UTRN ATP5F1C

1.04e-0813531692529467282
Pubmed

Hague (Hag). A new mouse hair mutation with an unstable semidominant allele.

KRT1 KRT5 KRT6A KRT6B KRT75

1.07e-0816169512399393
Pubmed

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.

MAGEA4 KRT1 KRT5 KRT6A KRT6B FMR1 DSC1 MYO5B ARGLU1 DARS1 YTHDC2 HEATR1 CIT EIF6 ITPR2 HARS2 PARP1 AP2B1 PIP SLMAP SMARCA1 MVP PML ATP5F1C

1.14e-0812571692436526897
Pubmed

EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.

KRT1 KRT5 KRT6A KRT6B AARS1 HK1 ARGLU1 MTHFD1L CEP162 DARS1 DCTN1 CIRBP PARP1 KRT6C AP2B1 SMARCA1 MVP TPD52L2 ATP5F1C

1.56e-088031691936517590
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

DCHS2 AARS1 AHCYL1 ARGLU1 ANXA7 ZBTB4 DARS1 QRICH1 DCTN1 CIT RPH3A HMG20A CCDC13 PARP1 UBE2O AP2B1 MACF1 MVP UTRN SNX1 AGAP2 DOP1B ZNF292 SOS1

1.73e-0812851692435914814
Pubmed

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.

MPP1 DCHS2 AARS1 MTHFD1L CARMIL1 ANXA7 YTHDC2 SMC5 TRRAP VPS13D PPP4C XIRP2 PIK3C2B ZNF292 HELLS

2.43e-084971691536774506
Pubmed

A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.

PRPSAP1 KRT1 SMG1 HIP1 HK1 IQGAP2 MTHFD1L ANXA7 RANBP6 CARD10 YTHDC2 HEATR1 ITPR2 EVI5 PARP1 PPP2R1B THADA NCAPG IPO9 PPP4C AP2B1 DHX29 PML ATP5F1C HELLS

3.50e-0814401692530833792
Pubmed

The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.

KRT1 KRT5 KRT6A KRT6B AHCYL1 ACTG2 DARS1 YTHDC2 RO60 DCTN1 CIRBP PARP1 UBE2O NCAPG KRT75 KRT6C AP2B1 AMOT AGL MACF1 DHX29 ATP5F1C

4.97e-0811531692229845934
Pubmed

KAP1 facilitates reinstatement of heterochromatin after DNA replication.

PRPSAP1 HK1 IQGAP2 MTHFD1L ANXA7 DARS1 YTHDC2 HEATR1 DCTN1 TRRAP EIF6 NCAPG PPP4C AGL SMARCA1 DHX29 ATP5F1C

7.00e-087041691729955894
Pubmed

Genetic variants in pachyonychia congenita-associated keratins increase susceptibility to tooth decay.

KRT6A KRT6B KRT6C

1.13e-073169329357356
Pubmed

Cytokeratin 5/6 expression in bladder cancer: association with clinicopathologic parameters and prognosis.

KRT5 KRT6A KRT6B

1.13e-073169329587848
Pubmed

Mice expressing a mutant Krt75 (K6hf) allele develop hair and nail defects resembling pachyonychia congenita.

KRT6A KRT6B KRT75

1.13e-073169317851587
Pubmed

Keratin expression provides novel insight into the morphogenesis and function of the companion layer in hair follicles.

KRT6A KRT6B KRT75

1.13e-073169317170733
Pubmed

Cloning and characterization of multiple human genes and cDNAs encoding highly related type II keratin 6 isoforms.

KRT6A KRT6B KRT6C

1.13e-07316937543104
Pubmed

Identification of a cloned sequence activated during multi-stage carcinogenesis in mouse skin.

KRT1 KRT6A KRT6B

1.13e-07316931713533
Pubmed

Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.

HK1 CEP162 TSN BCL6 DCTN1 KHDC4 USP19 EPG5 MEN1 CIRBP THADA BRD8 AGL VAMP1 SLMAP MAPK7 DHX29 PML HELLS

1.42e-079251691928986522
Pubmed

The Interleukin-2-mTORc1 Kinase Axis Defines the Signaling, Differentiation, and Metabolism of T Helper 1 and Follicular B Helper T Cells.

IQGAP2 TACC2 BCL6 ITPR2 TXNIP PIK3C2B ASPM GNA11 RASAL1 AGAP2

1.86e-072271691026410627
Pubmed

Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.

AHCYL1 HK1 DSC2 ARGLU1 MTHFD1L NIBAN2 HEATR1 DCTN1 EIF6 AKAP12 ITPR2 PARP1 THADA UBE2O NCAPG SLMAP ASPM MACF1 AKAP1 DHX29 SNX1 PML TPD52L2 HELLS

2.57e-0714871692433957083
Pubmed

Large-scale mapping of human protein-protein interactions by mass spectrometry.

PRPSAP1 MYH4 IQGAP2 MTHFD1L CEP162 RO60 HEATR1 DCTN1 TRRAP QRICH2 EIF6 MEN1 CIRBP GTF2A2 NCAPG IPO9 PPP4C AP2B1 PIP SLMAP ASPM HELLS

3.15e-0712841692217353931
Pubmed

SERBP1 Promotes Stress Granule Clearance by Regulating 26S Proteasome Activity and G3BP1 Ubiquitination and Protects Male Germ Cells from Thermostimuli Damage.

AARS1 AHCYL1 HIP1 DSC1 USP24 DARS1 TSN QRICH1 NIBAN2 USP19 AKAP12 EXOC8 NCAPG IPO9 AP2B1 AMOT PIP ZNF292

3.19e-078781691837223481
Pubmed

RNF208, an estrogen-inducible E3 ligase, targets soluble Vimentin to suppress metastasis in triple-negative breast cancers.

KRT1 KRT5 KRT6A KRT6B KRT75 KRT6C

3.56e-0757169631862882
Pubmed

Faciogenital Dysplasia 5 supports cancer stem cell traits in basal-like breast cancer by enhancing EGFR stability.

KRT1 KRT5 KRT6A MYH4 KRT6B DARS1 AP2B1 MACF1 UTRN

4.41e-07191169933762435
Pubmed

An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.

FKBP15 AARS1 PDE8A IQGAP2 MYO5B CARMIL1 UBE3B CHEK1 HEATR1 DCTN1 MELK AKAP12 EXOC8 HMG20A THADA IPO9 AP2B1 AMOT PTPRQ VSIG8 RSPH9 CCDC40

5.07e-0713211692227173435
Pubmed

RAD21 cooperates with pluripotency transcription factors in the maintenance of embryonic stem cell identity.

KRT1 KRT5 KRT6A KRT6B EIF6 PARP1 PML HELLS

6.28e-07146169821589869
Pubmed

HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP.

KRT1 DARS1 TRRAP MACF1 UTRN

6.34e-0734169525925205
Pubmed

New consensus nomenclature for mammalian keratins.

KRT1 KRT5 KRT6A KRT6B KRT75 KRT6C

6.51e-0763169616831889
Pubmed

SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling.

KRT1 KRT5 KRT6A KRT6B FMR1 DSC1 MTHFD1L DARS1 DCTN1 CIT PARP1 PIK3C2B PIP MVP

6.71e-075581691427591049
Pubmed

Desmosomal localization of beta-catenin in the skin of plakoglobin null-mutant mice.

KRT1 KRT5 DSC1 DSC2

7.04e-071516949847250
Pubmed

Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.

FKBP15 KRT5 MYH4 KRT6B DSC1 RRM2B ACTG2 DARS1 HEATR1 AP2B1 PIP MACF1 VSIG8 MVP UTRN SNX1 ATP5F1C

8.79e-078441691725963833
Pubmed

FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells.

PRPSAP1 MTHFD1L NIBAN2 DCTN1 AKAP12 NCAPG IPO9 AGL HELLS

1.05e-06212169933462405
Pubmed

Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT).

KRT1 KRT5 KRT6A KRT6B TPRG1L DSC2 CARMIL1 ANXA7 PIP GNA11 MVP DOP1B

1.06e-064171691219199708
Pubmed

A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.

SMG1 FMR1 BCL6 DCTN1 AKAP12 XIRP2 AMOT AGL SLMAP TRIM55 MACF1 AKAP1 UTRN

1.08e-064971691323414517
Pubmed

Role for keratins 6 and 17 during wound closure in embryonic mouse skin.

KRT5 KRT6A KRT6B

1.12e-065169312557214
Pubmed

The diagnostic utility of D2-40, calretinin, CK5/6, desmin and MOC-31 in the differentiation of mesothelioma from adenocarcinoma in pleural effusion cytology.

KRT5 KRT6A KRT6B

1.12e-065169323075894
Pubmed

Airway hillocks are injury-resistant reservoirs of unique plastic stem cells.

KRT5 KRT6A KRT6B

1.12e-065169338693267
Pubmed

Pachyonychia Congenita

KRT6A KRT6B KRT6C

1.12e-065169320301457
Pubmed

Three epidermal and one simple epithelial type II keratin genes map to human chromosome 12.

KRT5 KRT6A KRT6B

1.12e-06516931713141
Pubmed

In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.

KRT1 KRT6A DSC1 DSC2 ANXA7 SLC44A2 ACTG2 SI TMC4 NIBAN2 EIF6 F9 PPP2R1B KRT75 KRT6C PIP GNA11 FUCA2 DOP1B

1.27e-0610701691923533145
Pubmed

A functional reference map of the RNF8 interactome in cancer.

KRT1 KRT5 KRT6A KRT6B DSC1 EIF6 PARP1 AP2B1 ATP5F1C

1.33e-06218169935831895
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

KRT1 KRT5 HK1 DSC2 IQGAP2 CEP162 USP19 AKAP12 THADA AMOT SCLT1 AKAP1 SNX1 TPD52L2 ATP5F1C HELLS

1.41e-067771691635844135
Pubmed

FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.

AARS1 FMR1 DARS1 DCTN1 HMG20A TXNIP NCAPG IPO9 AP2B1 SMARCA1 MACF1 MVP ATP5F1C HELLS

1.60e-066011691433658012
Pubmed

Mitochondrial Raf1 Regulates Glutamine Catabolism.

HK1 DSC1 DARS1 NIBAN2 CIT FMNL3 ASPM ARHGAP45 TPD52L2 ATP5F1C

1.63e-062881691038496616
Pubmed

Network organization of the human autophagy system.

KRT1 MYH4 HK1 FMR1 DSC1 IQGAP2 CHEK1 PARP1 XIRP2 AMOT AGL UTRN

1.72e-064371691220562859
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

AARS1 HK1 FMR1 DSC1 MTHFD1L DARS1 YTHDC2 RO60 HEATR1 DCTN1 EIF6 USP19 PARP1 THADA UBE2O NCAPG IPO9 AMOT SMARCA1 DHX29 ATP5F1C HELLS

1.77e-0614251692230948266
Pubmed

Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.

SMG1 FMR1 RRM2B YTHDC2 TRRAP ITPR2 PARP1 PPP2R1B PPP4C AMOT DHX29 PML

1.84e-064401691234244565
Pubmed

Adenomatous polyposis coli (APC) is required for normal development of skin and thymus.

KRT1 KRT5 KRT6A KRT6B

1.97e-0619169417002498
Pubmed

Identification of 14-3-3sigma mutation causing cutaneous abnormality in repeated-epilation mutant mouse.

KRT5 KRT6A KRT6B

2.23e-066169316239341
Pubmed

Keratin 6 is not essential for mammary gland development.

KRT5 KRT6A KRT6B

2.23e-066169316790075
Pubmed

p63(+)Krt5(+) distal airway stem cells are essential for lung regeneration.

KRT5 KRT6A KRT6B

2.23e-066169325383540
Pubmed

DDX24 promotes metastasis by regulating RPL5 in non-small cell lung cancer.

KRT1 SMG1 KRT5 DSC1 KRT75 AP2B1 PIP SIMC1 VSIG8

2.73e-06238169935864588
Pubmed

Identifying biological pathways that underlie primordial short stature using network analysis.

KRT5 KRT6A MYO5B ARGLU1 DARS1 YTHDC2 HEATR1 TRRAP CIT EIF6 ITPR2 PARP1 KRT6C AMOT MACF1 UTRN ATP5F1C HELLS

2.83e-0610241691824711643
Pubmed

A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.

MPP1 KRT6A FMR1 DARS1 YTHDC2 NIBAN2 SMC5 EIF6 AKAP12 AMOT MACF1 DHX29 ZNF292 TPD52L2 HELLS

2.84e-067241691536232890
Pubmed

Mouse screen reveals multiple new genes underlying mouse and human hearing loss.

AHCYL1 DSC2 MTHFD1L CARMIL1 UBE3B USP24 DENND1C DCTN1 TRRAP CIT MELK EVI5 BRD8 TTLL11 ASPM APOL4 ATP11A PLXNA2 DOP1B TPD52L2

2.90e-0612421692030973865
Pubmed

AP-2 factors act in concert with Notch to orchestrate terminal differentiation in skin epidermis.

KRT1 KRT5 KRT6A KRT6B

3.02e-0621169418824566
Pubmed

Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy.

KRT1 KRT5 KRT6B DSC1 MTHFD1L TSN HEATR1 EIF6 PARP1 NCAPG KRT6C AMOT PIP ATP5F1C

3.38e-066411691436057605
Pubmed

Characterization of the EGFR interactome reveals associated protein complex networks and intracellular receptor dynamics.

DARS1 EXOC8 PPP2R1B THADA IPO9 AP2B1 DOP1B SOS1

3.42e-06183169823956138
Pubmed

Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes.

KRT1 KRT5 KRT6A KRT6B DSC1 ASPM

3.58e-0684169629563501
Pubmed

Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.

CCDC14 EME1 CEP162 MEN1 UBE2O BRD8 NCAPG IPO9 AMOT UTRN SNX1 TPD52L2 ATP5F1C HELLS

3.63e-066451691425281560
Pubmed

A High-Density Human Mitochondrial Proximity Interaction Network.

KRT5 KRT6A HK1 FMR1 ARGLU1 MTHFD1L RANBP6 YTHDC2 TACC2 CHEK1 HEATR1 USP19 ATL1 ITPR2 HARS2 PARP1 VPS13D THADA PTAR1 SLMAP AKAP1 ATP5F1C

3.86e-0614961692232877691
Pubmed

Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel.

KRT5 KRT6A KRT6B

3.89e-067169319720911
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

AARS1 HK1 FMR1 MTHFD1L USP24 YTHDC2 HEATR1 TRRAP EIF6 UBE2O AP2B1 MACF1 MVP UTRN

4.18e-066531691422586326
Pubmed

An Interaction Landscape of Ubiquitin Signaling.

CCDC14 HIP1 ARGLU1 UBE3B USP24 USP19 AP2B1 PIK3C2B SLMAP MACF1 MVP PML

4.58e-064811691228190767
Pubmed

ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.

KRT6A HIP1 FMR1 HEATR1 PPWD1 CIT EIF6 MEN1 PARP1 AP2B1 SMARCA1 MACF1 GNA11 PML

4.72e-066601691432780723
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

FKBP15 FMR1 IQGAP2 ARGLU1 KSR2 DCTN1 CIT RPH3A AKAP12 CCDC13 PARP1 UBE2O AP2B1 MACF1 RASAL1 AGAP2 TPD52L2

5.14e-069631691728671696
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

AARS1 CAMKK1 DSC2 CEP162 CARMIL1 CHEK1 MELK VPS13D IPO9 PIK3C2B AMOT MACF1 AKAP1 UTRN PML DOP1B

5.21e-068611691636931259
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

FKBP15 TMEM94 FSTL5 SMC5 USP19 EPG5 MACF1 ANKRD12 PLXNA2 ADGRL3 DOP1B

5.45e-064071691112693553
Pubmed

TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity.

KRT1 KRT5 KRT6A KRT6B DSC1 PIP

5.70e-0691169634445801
Pubmed

Ephrin-As, Eph receptors and integrin α3 interact and colocalise at membrane protrusions of U251MG glioblastoma cells.

KRT1 KRT5 KRT6A LAMB4 KRT6B SI KRT6C SOS1

5.89e-06197169823686814
Pubmed

Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.

IQGAP2 CEP162 TACC2 HEATR1 DCTN1 AKAP12 MEN1 BRD8 PTPRC VILL AMOT MACF1 GNA11 ATP11A ANKRD12 FUCA2 UTRN PML

6.19e-0610841691811544199
Pubmed

ASPM and CITK regulate spindle orientation by affecting the dynamics of astral microtubules.

CIT SLMAP ASPM

6.20e-068169327562601
Pubmed

RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.

KRT1 FKBP15 KRT5 KRT6A HEATR1 DCTN1 KRT75 AGL

7.07e-06202169824639526
Pubmed

Functional proteomics mapping of a human signaling pathway.

SMG1 RANBP6 QRICH1 NIBAN2 DCTN1 HMG20A EPG5 FMNL3 TXNIP PTPRC MACF1 UTRN FMNL1

7.09e-065911691315231748
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

HIP1 TMEM94 MTHFD1L UBE3B KSR2 ZBTB4 CARD10 DCTN1 TRRAP CIT EIF6 ITPR2 HDDC3 THADA PIK3C2B UCKL1 RASAL1 ARAP1

8.04e-0611051691835748872
Pubmed

CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.

KRT1 KRT5 KRT6A KRT6B FMR1 DSC1 EIF6 PARP1 KRT6C PIP SMARCA1 ATP5F1C HELLS

9.09e-066051691328977666
Pubmed

Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.

HIP1 FMR1 ARGLU1 MTHFD1L SMC5 RPH3A ITPR2 AMOT ACAN MACF1 AGAP2

9.14e-064301691132581705
Pubmed

TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence.

KRT1 KRT5 KRT6A KRT6B HEATR1 EIF6 CIRBP PARP1 AMOT SMARCA1 ATP5F1C

9.14e-064301691138172120
Pubmed

A mutant mouse with severe anemia and skin abnormalities controlled by a new allele of the flaky skin (fsn) locus.

KRT1 KRT6A KRT6B

9.27e-069169316093647
Pubmed

Type II keratins precede type I keratins during early embryonic development.

KRT5 KRT6A KRT6B

9.27e-069169316180309
Pubmed

RIP4 regulates epidermal differentiation and cutaneous inflammation.

KRT1 KRT6A KRT6B

9.27e-069169319626033
Pubmed

N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.

KRT6A DARS1 TSN SMC5 AKAP12 SLMAP MACF1 MVP UTRN PML

1.16e-053601691033111431
Pubmed

Stage- and subunit-specific functions of polycomb repressive complex 2 in bladder urothelial formation and regeneration.

KRT1 KRT5 KRT6A KRT6B

1.16e-0529169428049658
Pubmed

Identification of proximal SUMO-dependent interactors using SUMO-ID.

AHCYL1 TACC2 QRICH1 NIBAN2 PPWD1 PARP1 PIP SIMC1 PML TPD52L2 HELLS

1.23e-054441691134795231
Pubmed

A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.

SMG1 AHCYL1 PDE8A TMEM94 RRM2B NIBAN2 TRRAP AKAP12 THADA MACF1 GNA11 ATP11A UTRN TPD52L2

1.24e-057191691435337019
Pubmed

High-resolution genetic, physical, and transcript map of the mnd2 region of mouse chromosome 6.

ACTG2 DCTN1 M1AP

1.32e-051016939806835
Pubmed

Tumor suppressor BAP1 nuclear import is governed by transportin-1.

KRT1 KRT5 AARS1 HK1 IQGAP2 DARS1 DCTN1 EIF6 AKAP12 CIRBP PARP1 UBE2O IPO9 AP2B1 AMOT AGL MACF1 TPD52L2

1.36e-0511491691835446349
Pubmed

ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.

KRT1 KRT5 AARS1 AHCYL1 MTHFD1L RO60 NIBAN2 PARP1 AP2B1 AMOT SMARCA1

1.42e-054511691136168627
Pubmed

Suppression of DDX39B sensitizes ovarian cancer cells to DNA-damaging chemotherapeutic agents via destabilizing BRCA1 mRNA.

KRT5 KRT6A KRT6B DSC1 KRT6C PIP

1.45e-05107169632989256
Pubmed

An investigation into the human serum "interactome".

KRT1 KRT5 KRT6A KRT6B NLRP1 MACF1 ZNF292

1.53e-05162169715174051
Pubmed

Proteomic and yeast 2-hybrid screens to identify PTEN binding partners.

MPP1 CIT PARP1 APOL4 UTRN TPD52L2 ATP5F1C HELLS

1.60e-05226169837839992
InteractionKRT36 interactions

KRT1 KRT5 KRT6A KRT6B EXOC8 KRT75 KRT6C AMOT

1.95e-07741698int:KRT36
InteractionKRT25 interactions

KRT1 KRT5 KRT6A KRT6B KRT75 KRT6C

4.22e-07351696int:KRT25
InteractionPHTF1 interactions

KRT5 KRT6A KRT6B KRT75 KRT6C

5.47e-07201695int:PHTF1
InteractionCFTR interactions

KRT1 KRT5 KRT6A MYH4 KRT6B AARS1 AHCYL1 HIP1 HK1 DSC1 CAMKK1 ARGLU1 ACTG2 DARS1 DCTN1 USP19 AKAP12 EXOC8 MEN1 HDDC3 PARP1 PPP2R1B THADA NCAPG IPO9 KRT75 KRT6C AP2B1 PIP MACF1 GNA11 MVP

6.18e-07148016932int:CFTR
InteractionDES interactions

KRT1 KRT5 KRT6A KRT6B CIT M1AP KRT75 KRT6C XIRP2 TRIM55

9.05e-0715816910int:DES
InteractionPIBF1 interactions

CCDC14 TSNAXIP1 CEP162 ZBTB4 USP24 CARD10 CIT CCDC13 AMOT PTPRQ ARHGAP45

1.03e-0620016911int:PIBF1
InteractionEED interactions

KRT1 KRT6A AARS1 HIP1 MYO5B ARGLU1 MTHFD1L ANXA7 DARS1 NIBAN2 HEATR1 SMC5 PPWD1 DCTN1 TRRAP CIT EIF6 MEN1 FMNL3 PARP1 THADA IPO9 AP2B1 VILL XIRP2 SMARCA1 TRIM55 MACF1 MVP ATP5F1C HELLS

1.13e-06144516931int:EED
InteractionNAA40 interactions

FKBP15 AARS1 DSC1 CARMIL1 DARS1 YTHDC2 TACC2 NIBAN2 HEATR1 SMC5 DCTN1 CIT EIF6 AKAP12 PARP1 UBE2O AP2B1 MACF1 AKAP1 DHX29 UTRN SNX1 PML HELLS

2.27e-0697816924int:NAA40
InteractionKRT84 interactions

KRT5 KRT6A KRT6B DCTN1 KRT75 KRT6C

3.30e-06491696int:KRT84
InteractionEFNA3 interactions

KRT1 KRT5 KRT6A LAMB4 KRT6B SI KRT6C SOS1

3.58e-061081698int:EFNA3
InteractionMCM2 interactions

FKBP15 KRT5 MYH4 KRT6B DSC1 RRM2B KSR2 ACTG2 DARS1 CHEK1 HEATR1 TRRAP MEN1 PARP1 UBE2O PPP4C AP2B1 PIP MACF1 VSIG8 MVP UTRN SNX1 PML ATP5F1C

3.91e-06108116925int:MCM2
InteractionKRT28 interactions

KRT1 KRT5 KRT6A KRT6B KRT6C

4.70e-06301695int:KRT28
InteractionKCTD13 interactions

KRT1 KRT5 KRT6A LAMB4 AHCYL1 HK1 FMR1 IQGAP2 MYO5B ARGLU1 CARMIL1 DARS1 YTHDC2 BCAN DCTN1 CIT RPH3A ITPR2 PARP1 UBE2O AP2B1 AMOT MACF1 DNAH6 DHX29 UTRN RASAL1 AGAP2 ATP5F1C

4.85e-06139416929int:KCTD13
InteractionKRT7 interactions

KRT1 KRT5 KRT6A KRT6B RNF135 KRT75 KRT6C

4.89e-06801697int:KRT7
InteractionKRT24 interactions

KRT1 KRT5 KRT6B KRT75 KRT6C AMOT

5.89e-06541696int:KRT24
InteractionRAC1 interactions

PRPSAP1 AARS1 AHCYL1 HIP1 FMR1 PDE8A DSC2 IQGAP2 MYO5B CARMIL1 UBE3B NIBAN2 CIT MELK AKAP12 AP2B1 MACF1 GNA11 ATP11A UTRN FMNL1 ARAP1 AGAP2 SOS1

9.32e-06106316924int:RAC1
InteractionFGD5 interactions

KRT1 KRT5 KRT6A MYH4 KRT6B DARS1 TRRAP AP2B1 MACF1 UTRN

1.02e-0520716910int:FGD5
InteractionCDC5L interactions

FMR1 ARGLU1 USP24 CARD10 NIBAN2 CHEK1 SMC5 RNF17 PPWD1 KHDC4 CIT MELK PARP1 BRD8 IPO9 PPP4C TRIM55 MACF1 MVP PML HELLS

1.02e-0585516921int:CDC5L
InteractionKRT26 interactions

KRT1 KRT6A KRT6B KRT75 KRT6C

1.03e-05351695int:KRT26
InteractionFBXO22 interactions

MPP1 DCHS2 AARS1 MTHFD1L CARMIL1 ANXA7 YTHDC2 SMC5 TRRAP CIT VPS13D PPP4C XIRP2 PIK3C2B ZNF292 HELLS

1.32e-0554016916int:FBXO22
InteractionKRT20 interactions

KRT5 KRT6A KRT6B EXOC8 KRT75 KRT6C

1.46e-05631696int:KRT20
InteractionCDC42 interactions

PRPSAP1 AARS1 AHCYL1 FMR1 DSC2 IQGAP2 CARMIL1 KSR2 RO60 NIBAN2 HEATR1 TRRAP CIT MELK AKAP12 ITPR2 FMNL3 THADA IPO9 GNA11 ATP11A UTRN FMNL1 ARAP1 AGAP2 TPD52L2 ATP5F1C

1.52e-05132316927int:CDC42
InteractionZUP1 interactions

KRT1 FKBP15 KRT5 KRT6A KRT6B DSC1 ASPM ARHGAP45 UTRN

1.66e-051741699int:ZUP1
InteractionPRKAA1 interactions

FMR1 CAMKK1 KSR2 CHEK1 TXNIP PARP1 PPP2R1B UBE2O ASPM SCLT1 AGAP2

1.70e-0526816911int:PRKAA1
InteractionDCTN1 interactions

KRT5 KRT6A KRT6B CEP162 YTHDC2 DCTN1 CIT MEN1 UBE2O IPO9 KRT75 KRT6C MACF1 DHX29 SNX1

2.01e-0549716915int:DCTN1
InteractionKRT75 interactions

KRT1 KRT5 KRT6A KRT6B CARD10 DCTN1 KRT75 KRT6C AMOT

2.27e-051811699int:KRT75
InteractionCAPZB interactions

FKBP15 HIP1 MYO5B MTHFD1L CARMIL1 UBE3B DARS1 TSN TACC2 QRICH1 CHEK1 DCTN1 TRRAP CIT ITPR2 PARP1 UBE2O AP2B1 AMOT PLEKHO1 DHX29 ARAP1 SOS1

2.32e-05104916923int:CAPZB
InteractionNPHP3 interactions

KRT1 KRT5 PDE8A TXNIP PIP

2.59e-05421695int:NPHP3
InteractionPLK1 interactions

AHCYL1 DSC1 CEP162 RRM2B DCTN1 TRRAP EIF6 AKAP12 MEN1 CIRBP EVI5 UBE2O SIMC1 ASPM AKAP1

2.71e-0551016915int:PLK1
InteractionLUZP1 interactions

FMR1 CEP162 SMC5 DCTN1 CIT MEN1 SCLT1 AGAP2 PML

3.91e-051941699int:LUZP1
InteractionWTAP interactions

KRT1 KRT5 KRT6A KRT6B FMR1 BCL6 MEN1 UBE2O VSIG8

3.91e-051941699int:WTAP
InteractionHDAC2 interactions

MPP1 KRT1 KRT5 KRT6A KRT6B AARS1 FMR1 BCL6 SMC5 DCTN1 CIT USP19 HMG20A MEN1 TXNIP PARP1 NCAPG AP2B1 PML HELLS

3.97e-0586516920int:HDAC2
InteractionRNF208 interactions

KRT1 KRT5 KRT6A KRT6B KRT75 KRT6C

3.97e-05751696int:RNF208
InteractionNUMA1 interactions

FMR1 MYO5B SMC5 CIT MEN1 TXNIP PARP1 KRT75 ASPM SMARCA1 MACF1 DNAH6 PML HELLS

4.31e-0546916914int:NUMA1
InteractionKRT12 interactions

KRT5 KRT6A KRT6B KRT75

4.45e-05241694int:KRT12
InteractionCTIF interactions

SMG1 AHCYL1 DCTN1 CIT UBE2O AP2B1

4.61e-05771696int:CTIF
InteractionCOPS5 interactions

PRPSAP1 KRT1 KRT5 KRT6A DCHS2 KRT6B AHCYL1 MTHFD1L ANXA7 USP24 YTHDC2 RO60 CHEK1 CIRBP TXNIP PARP1 PPP4C KRT75 KRT6C AGL ANKRD12 DHX29 TPD52L2

4.98e-05110216923int:COPS5
InteractionNCAPG interactions

AHCYL1 RO60 HDDC3 HARS2 PARP1 NCAPG PIP GPR137B PML

5.36e-052021699int:NCAPG
InteractionRAC2 interactions

AHCYL1 HK1 PDE8A DSC2 CARMIL1 TRRAP MELK AKAP12 FMNL3 VPS13D AP2B1 MACF1 ATP11A AKAP1 UTRN FMNL1 AGAP2

5.43e-0567416917int:RAC2
InteractionKRT17 interactions

KRT1 KRT5 KRT6A KRT6B DSC1 KRT75 KRT6C TTLL11 PIP AGAP2

5.49e-0525216910int:KRT17
InteractionKRT18 interactions

CCDC14 KRT1 KRT5 KRT6A KRT6B CEP162 DARS1 SMC5 EXOC8 UBE2O KRT75 KRT6C PML

5.51e-0541916913int:KRT18
InteractionECT2 interactions

AHCYL1 FMR1 MYO5B ARGLU1 HEATR1 TRRAP CIT EIF6 ITPR2 PARP1 UBE2O IPO9 AP2B1 ASPM MACF1 GNA11 MVP PML DOP1B ATP5F1C

5.63e-0588716920int:ECT2
InteractionFXR1 interactions

MAGEA4 SMG1 BTBD6 FMR1 MYO5B TSN TACC2 DCTN1 CIT HMG20A MEN1 AP2B1 MAPK7 PLEKHO1 MVP PML TPD52L2

5.94e-0567916917int:FXR1
InteractionAPEX1 interactions

HK1 CEP162 TSN HEATR1 BCL6 SMC5 DCTN1 TRRAP KHDC4 USP19 EPG5 MEN1 CIRBP PARP1 THADA BRD8 AGL VAMP1 SLMAP SMARCA1 MAPK7 DHX29 PML ZNF292 HELLS

5.97e-05127116925int:APEX1
InteractionRHOA interactions

AHCYL1 HK1 DSC2 NIBAN2 HEATR1 TRRAP CIT AKAP12 ITPR2 FMNL3 HDDC3 PARP1 VPS13D IPO9 SLMAP MACF1 GNA11 ATP11A AKAP1 UTRN FMNL1 SNX1 AGAP2 ATP5F1C

6.50e-05119916924int:RHOA
InteractionRAB11A interactions

SDK2 HK1 DSC2 MYO5B CARMIL1 RANBP6 NIBAN2 AKAP12 ITPR2 EVI5 GPR161 PPP2R1B GNA11 AKAP1 FMNL1 SNX1 DOP1B TPD52L2 ATP5F1C

7.15e-0583016919int:RAB11A
InteractionCAPZA2 interactions

MYO5B CARMIL1 CARD10 DCTN1 CIT MEN1 ITPR2 PARP1 UBE2O MACF1 VSIG8 PLEKHO1 ARAP1

7.17e-0543016913int:CAPZA2
InteractionEFTUD2 interactions

PRPSAP1 KRT1 KRT5 KRT6A KRT6B MTHFD1L CARMIL1 USP24 DARS1 TSN TACC2 SMC5 PPWD1 DCTN1 CIT EIF6 MEN1 CIRBP PARP1 UBE2O NCAPG KRT6C AP2B1 MACF1 SNX1 ATP5F1C HELLS

7.38e-05144916927int:EFTUD2
InteractionCCDC138 interactions

CCDC14 CEP162 DCTN1 TRRAP AP2B1 AMOT SCLT1

8.09e-051231697int:CCDC138
InteractionEIF2S3B interactions

SMC5 TRRAP CIT UBE2O

9.62e-05291694int:EIF2S3B
InteractionKRT38 interactions

KRT1 KRT5 KRT6A KRT6B KRT75 KRT6C ASPM CCDC40

1.04e-041721698int:KRT38
InteractionMKI67 interactions

SMG1 FMR1 MTHFD1L KSR2 QRICH1 SMC5 TRRAP CIT MELK MEN1 FMNL3 PARP1 AP2B1 ASPM TRIM55 UTRN

1.16e-0464816916int:MKI67
InteractionTCHP interactions

CCDC14 KRT5 KRT6A CEP162 CCDC13 KRT75 AMOT

1.20e-041311697int:TCHP
InteractionCHD4 interactions

KRT1 KRT5 KRT6A KRT6B FMR1 DSC1 SMC5 DCTN1 CIT EIF6 MEN1 PARP1 UBE2O NCAPG KRT6C PIP SMARCA1 PML ATP5F1C HELLS

1.20e-0493816920int:CHD4
InteractionH2BC1 interactions

SMC5 TRRAP CIT HMG20A PARP1 UBE2O BRD8 IPO9

1.32e-041781698int:H2BC1
InteractionKRT15 interactions

KRT1 KRT5 KRT6A KRT6B EXOC8 KRT75 KRT6C AMOT

1.32e-041781698int:KRT15
InteractionKRT19 interactions

CCDC14 KRT1 KRT5 KRT6A KRT6B CEP162 EXOC8 KRT75 KRT6C AMOT

1.39e-0428216910int:KRT19
InteractionKIF23 interactions

FMR1 DSC1 MYO5B ARGLU1 YTHDC2 HEATR1 SMC5 CIT EIF6 BDKRB2 MEN1 ITPR2 PARP1 UBE2O ASPM MACF1 GNA11 SCLT1 MVP TPD52L2 ATP5F1C

1.52e-04103116921int:KIF23
InteractionYEATS4 interactions

KRT5 EME1 CEP162 TACC2 TRRAP HMG20A BRD8 ZNF292

1.54e-041821698int:YEATS4
InteractionCWF19L2 interactions

CARD10 SMC5 EXOC8 M1AP PARP1 UBE2O VAMP1 PML

1.54e-041821698int:CWF19L2
InteractionKRT77 interactions

KRT1 KRT5 KRT6A MYH4 DSC1 KRT75

1.58e-04961696int:KRT77
InteractionEP400 interactions

SMC5 TRRAP CIT MEN1 PARP1 PPP2R1B BRD8 PML

1.66e-041841698int:EP400
InteractionSNW1 interactions

TSNAXIP1 YTHDC2 NIBAN2 CHEK1 SMC5 PPWD1 DCTN1 CIT MEN1 PPP2R1B NCAPG IPO9 TRIM55 MVP ARAP1 PML HELLS

1.87e-0474716917int:SNW1
InteractionEFNA4 interactions

KRT1 KRT5 KRT6A KRT6B EXOC8 THADA KRT6C UCKL1 SOS1

1.93e-042391699int:EFNA4
InteractionPCNT interactions

CCDC14 AHCYL1 FMR1 CEP162 IPO9 AP2B1 AMOT MACF1 UTRN

2.05e-042411699int:PCNT
InteractionMYH9 interactions

AHCYL1 HIP1 MYO5B MTHFD1L CEP162 CARMIL1 SMC5 TRRAP CIT MEN1 ITPR2 NCAPG AP2B1 MACF1 DNAH6 MVP PML

2.09e-0475416917int:MYH9
InteractionDNTTIP2 interactions

HEATR1 SMC5 TRRAP CIT MEN1 PARP1 PML

2.16e-041441697int:DNTTIP2
InteractionNANOG interactions

KRT1 KRT5 KRT6B ARGLU1 TRRAP EIF6 MEN1 CIRBP PARP1 BRD8 SMARCA1 PML HELLS

2.17e-0448116913int:NANOG
InteractionFLII interactions

AHCYL1 RO60 DCTN1 TRRAP EIF6 PARP1 NCAPG MAPK7 AKAP1 FMNL1

2.17e-0429816910int:FLII
InteractionCLOCK interactions

TDRD9 DBP TRRAP KHDC4 HMG20A PPP2R1B

2.20e-041021696int:CLOCK
InteractionKRT14 interactions

KRT1 KRT5 KRT6A KRT6B UBE2O KRT75 KRT6C AMOT

2.22e-041921698int:KRT14
InteractionHECTD1 interactions

AHCYL1 FMR1 IQGAP2 DARS1 YTHDC2 TACC2 HEATR1 SMC5 DCTN1 TRRAP EIF6 PARP1 NCAPG AMOT ASPM MACF1 AKAP1 DHX29 UTRN ATP5F1C

2.27e-0498416920int:HECTD1
InteractionNIN interactions

CCDC14 KRT5 CEP162 RNF135 DCTN1 CIT EIF6 MEN1 AMOT PIP SCLT1

2.32e-0435916911int:NIN
InteractionARHGAP24 interactions

KRT1 KRT5 AARS1 AHCYL1 FMR1 MTHFD1L RO60 NIBAN2 PARP1 AP2B1 AMOT PIP SMARCA1

2.40e-0448616913int:ARHGAP24
InteractionTRIM28 interactions

PRPSAP1 HK1 FMR1 IQGAP2 MTHFD1L ANXA7 DARS1 TSN YTHDC2 HEATR1 SMC5 DCTN1 TRRAP CIT EIF6 MEN1 TXNIP PARP1 UBE2O NCAPG PPP4C AGL SMARCA1 DHX29 PML ATP5F1C

2.44e-04147416926int:TRIM28
InteractionHEXIM1 interactions

KRT1 KRT5 KRT6A KRT6B AHCYL1 ACTG2 DARS1 YTHDC2 DCTN1 CIRBP PARP1 UBE2O KRT75 KRT6C AP2B1 AMOT AGL MACF1 ATP5F1C

2.45e-0491316919int:HEXIM1
InteractionPRMT8 interactions

LRRC45 CEP162 CIRBP NCAPG AGAP2 PML

2.45e-041041696int:PRMT8
InteractionRAPGEF2 interactions

PRPSAP1 FMR1 BRD8 VSIG8 AGAP2 SOS1

2.58e-041051696int:RAPGEF2
InteractionCAPZA1 interactions

FKBP15 CARMIL1 TSN DCTN1 TRRAP CIT MEN1 PARP1 AKAP1 PLEKHO1 ARAP1

2.73e-0436616911int:CAPZA1
InteractionTNR interactions

FMR1 BCAN ACAN AGAP2

2.82e-04381694int:TNR
InteractionKIFC3 interactions

CCDC14 KRT5 KRT6A KRT6B BCL6 EXOC8 HMG20A KRT75 KRT6C

2.85e-042521699int:KIFC3
InteractionIQCB1 interactions

KRT1 KRT5 KRT6A KRT6B HK1 CEP162 UBE3B RNF135 IPO9 KRT6C ATP5F1C

3.00e-0437016911int:IQCB1
InteractionCRK interactions

KRT1 KRT5 KRT6A KRT6B DSC1 MEN1 AP2B1 PIK3C2B ADGRL3 ARAP1 SOS1

3.00e-0437016911int:CRK
InteractionTAF9B interactions

MPP1 FMR1 SMC5 TRRAP CIT PIP

3.01e-041081696int:TAF9B
InteractionRAB5A interactions

PRPSAP1 DSC2 NIBAN2 CIT AKAP12 TXNIP HDDC3 IPO9 SLMAP SMARCA1 MACF1 AKAP1 MVP SNX1 DOP1B TPD52L2

3.05e-0470616916int:RAB5A
InteractionNDC80 interactions

CCDC14 KRT6A KRT6B CEP162 DCTN1 EXOC8 KRT75 AMOT ASPM SCLT1

3.13e-0431216910int:NDC80
InteractionPML interactions

EME1 AHCYL1 TACC2 QRICH1 NIBAN2 HEATR1 BCL6 SMC5 PPWD1 ITPR2 PARP1 BRD8 NCAPG PIP SIMC1 MAPK7 PML TPD52L2 HELLS

3.21e-0493316919int:PML
InteractionKRT35 interactions

KRT1 KRT5 KRT6A KRT6B KRT75 KRT6C

3.48e-041111696int:KRT35
InteractionKDM1A interactions

CCDC14 KRT6A KRT6B FMR1 CEP162 RNF135 USP24 CARD10 CHEK1 DCTN1 TRRAP CIT HMG20A TXNIP NCAPG AMOT SCLT1 AKAP1 UTRN

3.56e-0494116919int:KDM1A
InteractionKRT8 interactions

CCDC14 KRT1 SMG1 KRT5 KRT6A KRT6B CEP162 DCTN1 THADA IPO9 KRT75 KRT6C

3.58e-0444116912int:KRT8
InteractionRUVBL1 interactions

SMG1 AHCYL1 CAMKK1 RO60 SMC5 TRRAP CIT MEN1 TXNIP UBE2O BRD8 NCAPG SMARCA1 MAPK7

3.60e-0457516914int:RUVBL1
InteractionSERBP1 interactions

AARS1 AHCYL1 HIP1 FMR1 DSC1 USP24 DARS1 TSN YTHDC2 QRICH1 NIBAN2 SMC5 TRRAP CIT USP19 AKAP12 EXOC8 HARS2 UBE2O NCAPG IPO9 AP2B1 AMOT PIP ZNF292

3.79e-04143216925int:SERBP1
InteractionHSP90B1 interactions

SMG1 PDE8A TRRAP CIT MEN1 TXNIP EVI5 UBE2O IPO9 ASPM MAPK7 AKAP1 FMNL1 PML ATP5F1C

3.91e-0465016915int:HSP90B1
InteractionHTT interactions

MPP1 HIP1 HK1 MYO5B USP24 BCAN DCTN1 TRRAP RPH3A ATL1 HMG20A CIRBP IPO9 AP2B1 GNA11 MVP RASAL1 PML ATP5F1C

3.96e-0494916919int:HTT
InteractionUBC interactions

CCDC14 HIP1 ARGLU1 UBE3B USP24 USP19 PARP1 AP2B1 PIK3C2B SLMAP PML TPD52L2

3.96e-0444616912int:UBC
InteractionKRT6A interactions

KRT5 KRT6A KRT6B ZBTB4 DCTN1 KRT75 KRT6C

4.10e-041601697int:KRT6A
InteractionSMC2 interactions

AHCYL1 NLRP1 RO60 DCTN1 EIF6 MEN1 TXNIP PARP1 NCAPG GPR137B

4.11e-0432316910int:SMC2
InteractionDLG4 interactions

MPP1 SDK2 FMR1 IQGAP2 ARGLU1 CIT EVI5 AP2B1 MACF1 ADGRL3 RASAL1 AGAP2

4.20e-0444916912int:DLG4
InteractionAFF4 interactions

FMR1 SMC5 MEN1 PARP1 UBE2O AP2B1

4.21e-041151696int:AFF4
InteractionFBXO32 interactions

PRPSAP1 KRT1 MYH4 MTHFD1L NIBAN2 DCTN1 AKAP12 NCAPG IPO9 AGL HELLS

4.29e-0438616911int:FBXO32
Cytoband12q13.13

KRT1 KRT5 KRT6A KRT6B KRT6C

5.12e-0667169512q13.13
Cytoband1q31

RO60 BCAN ASPM

4.55e-051916931q31
CytobandEnsembl 112 genes in cytogenetic band chr17q25

PRPSAP1 SDK2 LRRC45 TMEM94 QRICH2 UBE2O CCDC40

1.53e-043071697chr17q25
Cytoband17q25.1

SDK2 TMEM94 QRICH2 UBE2O

2.36e-0481169417q25.1
Cytoband6q24

FUCA2 UTRN

3.72e-04816926q24
Cytoband9q21.12

SMC5 PTAR1

5.95e-041016929q21.12
CytobandEnsembl 112 genes in cytogenetic band chr12q13

KRT1 KRT5 KRT6A KRT6B FMNL3 KRT75 KRT6C

1.03e-034231697chr12q13
GeneFamilyKeratins, type II

KRT1 KRT5 KRT6A KRT6B KRT75 KRT6C

6.63e-09271006609
GeneFamilyAminoacyl tRNA synthetases, Class II

AARS1 DARS1 HARS2

1.49e-04191003132
GeneFamilyHyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing

BCAN ACAN

1.80e-0441002574
GeneFamilyDesmosomal cadherins

DSC1 DSC2

6.25e-04710021188
GeneFamilyTudor domain containing

TDRD9 RNF17 AKAP1

1.11e-03371003780
CoexpressionGSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP

EME1 HIP1 SLC44A2 CHEK1 PPP2R1B NCAPG ASPM PLEKHO1 HELLS

3.70e-061871699M2984
CoexpressionGSE34515_CD16_POS_MONOCYTE_VS_DC_DN

MPP1 SMG1 IQGAP2 ZBTB4 DBP KHDC4 BRD8 GPR137B DOP1B

6.39e-062001699M8763
CoexpressionSMID_BREAST_CANCER_BASAL_UP

MAGEA4 KRT5 KRT6A KRT6B DSC2 ACTG2 TSN CHEK1 MELK GPR161 ACAN ASPM ATP11A RASAL1 PML HELLS

6.52e-0666216916M8124
CoexpressionBUSSLINGER_GASTRIC_IMMUNE_CELLS

SMG1 FMR1 ZBTB4 USP24 NLRP1 DARS1 YTHDC2 RO60 DENND1C SMC5 EPG5 ITPR2 FMNL3 TXNIP PARP1 PTPRC PTAR1 VAMP1 MACF1 ARHGAP45 PLEKHO1 UTRN FMNL1 ZNF292 SOS1

1.12e-05149216925M40023
CoexpressionMEBARKI_HCC_PROGENITOR_FZD8CRD_UP

HK1 LRRC45 MTHFD1L SLC44A2 CHEK1 CIT MELK FMNL3 GPR161 NCAPG ASPM TRIM55 PLEKHO1 PML

2.97e-0558816914M38992
CoexpressionMITSIADES_RESPONSE_TO_APLIDIN_DN

HEATR1 TRRAP MELK GPR161 PARP1 NCAPG ASPM MACF1 HELLS

3.75e-052501699M11318
CoexpressionGSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_DN

HEATR1 TRRAP MELK AGL GPR137B TAS1R2 ANKRD12 HELLS

3.94e-051941698M4683
CoexpressionGSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_DN

CCDC14 FKBP15 MTHFD1L HDDC3 NCAPG AP2B1 ASPM FUCA2

4.55e-051981698M8274
CoexpressionGSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_UP

CCDC14 PRPSAP1 HK1 TPRG1L RRM2B RNF135 DENND1C PARP1

4.55e-051981698M4704
CoexpressionGSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_DN

PRPSAP1 ARGLU1 CIRBP TXNIP VAMP1 MACF1 PLEKHO1 ARAP1

4.55e-051981698M7605
CoexpressionGSE29949_CD8_NEG_DC_SPLEEN_VS_DC_BRAIN_DN

PDE8A IQGAP2 RANBP6 TSN SMC5 KHDC4 VPS13D AP2B1

4.88e-052001698M8403
CoexpressionGSE28237_FOLLICULAR_VS_LATE_GC_BCELL_DN

MPP1 TPRG1L RRM2B HMG20A IPO9 ASPM MVP ATP5F1C

4.88e-052001698M4889
CoexpressionGSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP

PRPSAP1 HIP1 PDE8A IQGAP2 TSN KHDC4 HMG20A EVI5

4.88e-052001698M8500
CoexpressionGSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN

HIP1 IQGAP2 SLC44A2 CARD10 DENND1C BCL6 PTPRC VILL

4.88e-052001698M7526
CoexpressionGSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP

SMG1 RRM2B DENND1C F9 HMG20A PTPRC ABHD1 RSPH9

4.88e-052001698M6044
CoexpressionGSE3039_CD4_TCELL_VS_B1_BCELL_UP

CARMIL1 CARD10 TACC2 DCTN1 ITPR2 UBE2O AP2B1 AKAP1

4.88e-052001698M6466
CoexpressionGSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_UP

DBP KHDC4 BRD8 GNA11 ARHGAP45 DHX29 FMNL1 ARAP1

4.88e-052001698M6832
CoexpressionJI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP

KRT5 KRT6A KRT6B

7.18e-05131693MM743
CoexpressionDESCARTES_FETAL_STOMACH_SQUAMOUS_EPITHELIAL_CELLS

KRT5 KRT6A KRT6B KRT6C DLK2

7.34e-05671695M40299
CoexpressionSMID_BREAST_CANCER_NORMAL_LIKE_UP

KRT5 NLRP1 TXNIP PPP2R1B PTPRC VILL VAMP1 DLK2 ARHGAP45 PLEKHO1 FMNL1 SNX1

7.77e-0548516912M8513
CoexpressionHU_ANGIOGENESIS_DN

ANXA7 DARS1 GTF2A2 PLXNA2

9.33e-05371694M18833
CoexpressionKRIEG_HYPOXIA_NOT_VIA_KDM3A

MPP1 BTBD6 HK1 DSC2 MTHFD1L CARD10 NIBAN2 MELK AKAP12 GPR161 VPS13D UBE2O MAPK7 PLEKHO1 ZNF292

1.04e-0474616915M2469
CoexpressionGABRIELY_MIR21_TARGETS

CCDC14 TPRG1L YTHDC2 SMC5 EXOC8 PARP1 PTAR1 UTRN ZNF292

1.14e-042891699M2196
CoexpressionGU_PDEF_TARGETS_DN

KRT6A KRT6B KRT75 KRT6C

1.27e-04401694M10480
CoexpressionGSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP

SMG1 IQGAP2 TMEM94 USP24 MACF1 UTRN SOS1

1.73e-041801697M8239
CoexpressionVAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_9MO_UP

CHEK1 CIT MELK NCAPG ASPM APOL4

1.78e-041271696M40952
CoexpressionCAIRO_HEPATOBLASTOMA_CLASSES_UP

AARS1 USP24 DARS1 CHEK1 HEATR1 TRRAP PARP1 NCAPG AP2B1 ASPM SMARCA1 DOP1B TPD52L2

1.79e-0461216913M4772
CoexpressionGSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_DN

RRM2B BCL6 SMC5 PARP1 ARHGAP45 PLEKHO1 FMNL1

1.92e-041831697M8189
CoexpressionSMID_BREAST_CANCER_RELAPSE_IN_BONE_DN

MAGEA4 KRT5 KRT6A KRT6B DSC2 ACTG2 NLRP1 GPR161 ACAN

2.67e-043241699M2700
CoexpressionGSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP

CARMIL1 CIRBP PPP2R1B VPS13D THADA FUCA2 UTRN

3.01e-041971697M7403
CoexpressionGSE3982_MEMORY_CD4_TCELL_VS_TH1_UP

MAGEA4 DBP CIRBP TXNIP AGL MACF1 ARHGAP45

3.01e-041971697M5378
CoexpressionGSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_UP

PRPSAP1 AHCYL1 CHEK1 TXNIP KRT75 AP2B1 AGAP2

3.01e-041971697M5150
CoexpressionGSE14308_TH2_VS_TH17_DN

MTHFD1L RRM2B TMC4 PPP2R1B PTPRC PLEKHO1 PML

3.20e-041991697M3363
CoexpressionGSE24142_DN2_VS_DN3_THYMOCYTE_DN

CAMKK1 RRM2B CARD10 AKAP12 ITPR2 AKAP1 DOP1B

3.20e-041991697M4558
CoexpressionGSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN

KRT5 CAMKK1 ARGLU1 SLC44A2 HMG20A ITPR2 VAMP1

3.20e-041991697M7319
CoexpressionGSE17721_LPS_VS_PAM3CSK4_8H_BMDC_DN

FKBP15 TPRG1L PDE8A DARS1 IPO9 FUCA2 ATP5F1C

3.20e-041991697M3921
CoexpressionGSE22935_WT_VS_MYD88_KO_MACROPHAGE_48H_MBOVIS_BCG_STIM_UP

UBE3B AKAP12 PGM5 GNA11 DHX29 UTRN ATP5F1C

3.20e-041991697M7766
CoexpressionGSE37534_UNTREATED_VS_GW1929_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN

HIP1 RANBP6 YTHDC2 BCL6 HMG20A EVI5 GNA11

3.20e-041991697M8979
CoexpressionGSE22589_HEALTHY_VS_SIV_INFECTED_DC_DN

FSTL5 AKAP12 MEN1 ITPR2 AP2B1 DLK2 PML

3.20e-041991697M7809
CoexpressionGSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_UP

SMG1 PDE8A EPG5 FMNL3 THADA PIK3C2B MACF1

3.20e-041991697M9238
CoexpressionGSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP

BTBD6 TPRG1L IQGAP2 RO60 TXNIP THADA MVP

3.20e-041991697M9214
CoexpressionGSE14308_INDUCED_VS_NATURAL_TREG_DN

FMR1 RRM2B SMC5 ITPR2 VILL UCKL1 SLMAP

3.30e-042001697M3399
CoexpressionGSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_UP

CEP162 CARD10 FMNL3 PTPRC VAMP1 MAPK7 UTRN

3.30e-042001697M9354
CoexpressionGSE10273_LOW_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_DN

USP24 SLC44A2 TACC2 DBP CIRBP VPS13D UCKL1

3.30e-042001697M322
CoexpressionGSE27786_NKTCELL_VS_MONO_MAC_UP

PRPSAP1 MTHFD1L RRM2B SMC5 ITPR2 THADA ARHGAP45

3.30e-042001697M4870
CoexpressionGSE41978_WT_VS_ID2_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN

HIP1 PDE8A CAMKK1 SMC5 FMNL3 UBE2O MVP

3.30e-042001697M9549
CoexpressionGSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP

USP24 NLRP1 YTHDC2 QRICH1 PTPRC MACF1 FMNL1

3.30e-042001697M9889
CoexpressionGSE19198_1H_VS_6H_IL21_TREATED_TCELL_DN

HK1 HEATR1 EIF6 AKAP12 ATP11A PLXNA2 PML

3.30e-042001697M7232
CoexpressionGSE26030_UNSTIM_VS_RESTIM_TH1_DAY15_POST_POLARIZATION_UP

HIP1 RRM2B SLC44A2 BCL6 PPP2R1B UCKL1 ARAP1

3.30e-042001697M8569
CoexpressionGSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_UP

TPRG1L MTHFD1L USP24 AKAP12 ARHGAP45 UTRN ARAP1

3.30e-042001697M7175
CoexpressionEBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP

BCAN TXNIP AGL MACF1 MAPK7 AKAP1 UTRN

3.30e-042001697M78
CoexpressionGSE31082_DN_VS_DP_THYMOCYTE_DN

ANXA7 RANBP6 TXNIP PTPRC MAPK7 ARHGAP45 FMNL1

3.30e-042001697M5055
CoexpressionGSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP

QRICH1 PPP4C AP2B1 ATP11A ABHD1 PLEKHO1 FMNL1

3.30e-042001697M7911
CoexpressionGSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_DN

PRPSAP1 FKBP15 CARD10 NCAPG PTPRC ASPM ZNF292

3.30e-042001697M6601
CoexpressionGSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_DN

PRPSAP1 TPRG1L ZBTB4 RANBP6 TRRAP MEN1 PML

3.30e-042001697M6585
CoexpressionGSE22432_PDC_VS_TGFB1_TREATEDCOMMON_DC_PROGENITOR_DN

MPP1 RRM2B SLC44A2 DENND1C FMNL3 UCKL1 PML

3.30e-042001697M7833
CoexpressionGSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN

TACC2 CHEK1 MELK AKAP1 PLEKHO1 PML HELLS

3.30e-042001697M9215
CoexpressionGOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP

EME1 AARS1 CHEK1 CIT MELK AKAP12 FMNL3 GPR161 NCAPG ASPM PLEKHO1 HELLS

3.90e-0457816912M2368
ToppCellsevere-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SMG1 ARGLU1 USP24 AKAP12 PTPRC MACF1 ANKRD12 UTRN ZNF292 HELLS

4.50e-091971691057ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell(11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition

CEP162 ZBTB4 DARS1 EIF6 EVI5 VPS13D ANKRD12 DHX29 UTRN SOS1

4.72e-091981691076d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCellCV-Moderate-7|CV / Virus stimulation, Condition and Cluster

CCDC14 HEATR1 KHDC4 ITPR2 PTPRC MACF1 DOP1B ZNF292 HELLS

4.11e-0818616998571956890fc9894d766ba294a28e376b4aba428
ToppCellTCGA-Head_and_Esophagus|World / Sample_Type by Project: Shred V9

KRT1 KRT5 KRT6A KRT6B DSC1 DSC2 KRT75 KRT6C

3.20e-071721698eb18aa179db1818f408c38e442ecfed8582d7dbc
ToppCell343B-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

CHEK1 MELK GPR161 CCDC13 NCAPG ASPM PML HELLS

4.16e-071781698c7e890cd02206c516cf1d7692ea7abc8ce746482
ToppCell390C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells)

EME1 CHEK1 CIT MELK GPR161 NCAPG ASPM HELLS

4.34e-071791698e67ad7ab04d0c1309296f57c1f53c5ca14c213fe
ToppCell343B-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells)

CHEK1 MELK GPR161 CCDC13 NCAPG ASPM PML HELLS

4.92e-071821698b1e66ccd5f33b4801f1cafddf97f5fc0c6dba8d1
ToppCellTCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9

KRT1 KRT5 KRT6A KRT6B DSC1 DSC2 KRT75 KRT6C

6.82e-0719016983188c7bd225cbcf46a21e2fb784336cdd9665995
ToppCellTCGA-Skin-Primary_Tumor|TCGA-Skin / Sample_Type by Project: Shred V9

KRT1 KRT5 KRT6A KRT6B DSC1 DSC2 KRT75 KRT6C

6.82e-071901698e2b26a03c6ab24d9b0f4150c47597be37767d86e
ToppCellTCGA-Skin-Primary_Tumor-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9

KRT1 KRT5 KRT6A KRT6B DSC1 DSC2 KRT75 KRT6C

6.82e-07190169801fb45add4661bc86cd0a34fac35177907152dbb
ToppCellsevere-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SMG1 ARGLU1 USP24 AKAP12 MACF1 ANKRD12 UTRN ZNF292

7.67e-0719316989337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ARGLU1 RNF17 TXNIP PTPRC MACF1 ANKRD12 UTRN HELLS

8.62e-071961698ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de
ToppCell3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

KRT5 KRT6A KRT6B CHEK1 MELK NCAPG KRT6C HELLS

8.95e-0719716982430f31d9312338e0ca23bfc6bdb0365340860fd
ToppCellproximal-Epithelial-Proliferating_Basal|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

KRT5 KRT6A CHEK1 MELK NCAPG ASPM DLK2 HELLS

9.66e-071991698521ff4ae3437c8ba477a0a42b9da195af976c3ff
ToppCellproximal-Epithelial-Proliferating_Basal-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

KRT5 KRT6A CHEK1 MELK NCAPG ASPM DLK2 HELLS

9.66e-071991698e8549b2c4152cb23548351d9cee27c3805892cd8
ToppCellproximal-3-Epithelial-Proliferating_Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

KRT5 KRT6A CHEK1 MELK NCAPG ASPM DLK2 HELLS

9.66e-0719916982263bb73d9c5693b44d91d2548305efc1b6e4079
ToppCellBiopsy_Other_PF-Epithelial-Proliferating_Epithelial_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type

KRT5 KRT6A CHEK1 CIT MELK NCAPG ASPM HELLS

9.66e-071991698d73667e2e93026d95184e24ff0bc90afd1fb74a9
ToppCellTCGA-Stomach-Primary_Tumor|TCGA-Stomach / Sample_Type by Project: Shred V9

TSN CHEK1 HEATR1 MELK IPO9 ASPM ATP11A HELLS

9.66e-07199169838f1f612b29feb868322999ceeda78e52447ec4f
ToppCellTCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma|TCGA-Stomach / Sample_Type by Project: Shred V9

TSN CHEK1 HEATR1 MELK IPO9 ASPM ATP11A HELLS

9.66e-071991698b10698aee2e6c17bc559eb4f723024141f914b90
ToppCellTransverse-B_cell-B_cell_cycling|B_cell / Region, Cell class and subclass

CCDC14 TACC2 BCL6 CIT MELK NCAPG ASPM RSPH9

9.66e-071991698170ae68963d31f3b821b6f0e8f0c039bea0bc981
ToppCellTransverse-(2)_B_cell-(24)_B_cell_cycling|Transverse / shred on region, Cell_type, and subtype

CCDC14 TACC2 CHEK1 CIT MELK NCAPG ASPM RSPH9

1.00e-062001698e3f9736227151f23f0e331eec0a7a15ce464b517
ToppCellTransverse-B_cell-B_cell_cycling|Transverse / Region, Cell class and subclass

CCDC14 TACC2 CHEK1 CIT MELK NCAPG ASPM RSPH9

1.00e-0620016980e270f8019d9f22068ca426d661937262a5cd331
ToppCellPSB-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

KRT5 EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

1.00e-0620016983e3de496508efb2f95e5e8684f97687381e96493
ToppCellhealthy_donor|World / Disease condition, Lineage, Cell class and subclass

SLC44A2 NLRP1 CIRBP TXNIP PTPRC MACF1 ARHGAP45 UTRN

1.00e-062001698afd4d5609adaa470e3d880f8be4a4d55e162b3d6
ToppCellCOVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class

SMG1 TXNIP PTPRC ANKRD12 PLEKHO1 UTRN FMNL1 ZNF292

1.00e-06200169862c25042086f1afd1102e0720e933c2e476468fd
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TSNAXIP1 EME1 CHEK1 MELK RPH3A NCAPG HELLS

1.60e-06148169718cfecd6ae20edb74f5d44ba759909df356acf3a
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

EME1 MELK IQCA1L NCAPG PTPRC ASPM ARHGAP45

4.67e-0617416977b318796728001c17b4043d2b033330c7be40c78
ToppCellPND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

4.67e-06174169772df66319f6efbd88ecf439013d97409fbf3cb52
ToppCellPND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

4.67e-061741697c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235
ToppCell390C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

EME1 CHEK1 CIT MELK GPR161 NCAPG ASPM

5.03e-0617616978813c01ea080f373fe3970c5e1ba4c2dca0f7f02
ToppCell3'_v3-Lung-Lymphocytic_T_CD4/8-lo-Cycling_T|Lung / Manually curated celltypes from each tissue

EME1 ACTG2 CHEK1 MELK NCAPG ASPM HELLS

5.03e-061761697a40dfd8c4ba16757ff929b2f03a0628acf334de4
ToppCellBAL-Control-cDC_8|Control / Compartment, Disease Groups and Clusters

IQANK1 CEP162 AKAP12 PGM5 GPR161 ABHD1 SCLT1

6.04e-061811697f370161afef2ec827a7b194c06abb9ac1a507cbb
ToppCellBasal|World / shred by cell class for mouse tongue

KRT5 HIP1 CARD10 DBP TXNIP DLK2 PLXNA2

6.50e-061831697c6729a207526ff4aa48176207b9353176f631fea
ToppCellCOVID-cycling-|COVID / Condition, Cell_class and T cell subcluster

CHEK1 CIT MELK NCAPG ASPM CCDC40 HELLS

6.97e-061851697eb74b8d36f7b749e04bc2ed4b36f7e1ac7bb6d5f
ToppCellCV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster

HEATR1 KHDC4 PTPRC MACF1 DOP1B ZNF292 HELLS

6.97e-061851697a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

KSR2 CHEK1 CIT MELK NCAPG ASPM HELLS

6.97e-0618516979d424a8608b339dd6129c58d87626678d4ec4af7
ToppCellCOVID-cycling|COVID / Condition, Cell_class and T cell subcluster

CHEK1 CIT MELK NCAPG ASPM CCDC40 HELLS

6.97e-0618516975112f966735fa48f0606adcfd5c0212ad5d3d77a
ToppCelldroplet-Tongue-nan-24m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KRT6A KRT6B DSC1 DSC2 MYO5B VSIG8 PLXNA2

7.22e-0618616972913b5fd0617d024d600ba7015ec7b1961dade83
ToppCellTCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9

KRT1 KRT6A KRT6B DSC1 DSC2 KRT75 KRT6C

7.48e-0618716972ca7928baf0c5e61f7294ed05e6e6f0e0adf9d3f
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

KRT5 KRT6A KRT6B KRT6C APOL4 RASAL1 PML

7.48e-061871697a6a112689d1c9049f57935ad9d2f4955538427de
ToppCell10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue

SMG1 USP24 EPG5 PTPRC MACF1 ANKRD12 UTRN

7.75e-061881697ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCellMultiple_Sclerosis-Lymphocyte-T_NK-T_NK_proliferative|Multiple_Sclerosis / Disease, Lineage and Cell Type

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

7.75e-0618816976c05797a5d0635d89ffcf4aca52178687129ccb4
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

IQGAP2 HEATR1 PPWD1 THADA MACF1 UTRN ZNF292

8.30e-06190169791ba66d4b56c59523485b17738e93f14bb00afa4
ToppCellPCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

ACTG2 CHEK1 CIT MELK NCAPG ASPM PLXNA2

8.30e-061901697e83fa8b711aa79a1767818474f1c193b674b1c31
ToppCellpdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

CIT MELK NCAPG IPO9 ASPM SCLT1 HELLS

8.30e-061901697d06ee5f89f1cec8db6897fe3b2a890a07cd3697b
ToppCellCOVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type

CHEK1 CIT MELK NCAPG PTPRC ASPM HELLS

8.59e-061911697bae388e0e9447d576e68465d73d8313ef6925ffa
ToppCellhuman_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

CHEK1 CIT MELK NCAPG ASPM SCLT1 HELLS

9.19e-0619316974b9fa2a4424f8abe63fa7bee78db93dda04ab15f
ToppCellPBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

9.51e-061941697f39a471293ecc5c5967b00e772b8f48ebc9affbe
ToppCelldroplet-Tongue-TONGUE-1m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KRT6A KRT6B DSC2 MYO5B DBP ANKRD12 PLXNA2

9.51e-061941697a3adcdc8b87332e8beb9bcd70cf36424af10633d
ToppCelldroplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FMR1 RRM2B AKAP12 PARP1 TTLL11 ASPM RSPH9

9.51e-0619416978ef0b71fef5b84cfd04973f891215333e7035d1d
ToppCellPBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

9.51e-061941697a75ecd0b0a928d4646602f7d16a645f6b3df3af5
ToppCellPBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

9.51e-06194169717744fd6645cf5a447a01a83f07e8d305c2bcd9c
ToppCellBLOOD--(1)_T_cell-(1)_Activated_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

IQGAP2 CHEK1 MELK EIF6 PARP1 NCAPG ASPM

9.51e-0619416976a0cbb9d5c5c4effb02dff654c6c3b184026875c
ToppCellmoderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CCDC14 SMC5 MELK AP2B1 ASPM UTRN HELLS

9.51e-061941697dff3fb10372053951d41e0ccd41aac3ece6009bd
ToppCellPBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

9.51e-061941697e14f66f7584909621b776292fbd52808273fd2ee
ToppCellHealthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

9.83e-061951697957458fdc39723f4a31bd7fd3ce32891aa3fd462
ToppCellHealthy-T/NK_proliferative|Healthy / disease group, cell group and cell class

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

1.02e-05196169791e44aabb2e85dcc77ddae6f7e000118d45d1de6
ToppCellControl-T/NK_proliferative|Control / Disease condition and Cell class

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

1.02e-0519616977b7bc25aef49bfd64f79303a92d527bf8188f7a6
ToppCellHealthy-T/NK_proliferative|World / disease group, cell group and cell class

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

1.05e-051971697e90be1e7e02f736b6aab14010a912b592d6f1e80
ToppCellHealthy/Control-T/NK_proliferative|World / Disease group and Cell class

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

1.05e-0519716974a4d3083938783d6f5b87da02f10e501917da0b4
ToppCellBronchial-10x5prime-Epithelial-Epi_airway_basal-Dividing_Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

EME1 CHEK1 MELK NCAPG KRT75 ASPM HELLS

1.05e-05197169725bbe270d0897b9b1bd00d205f66efd1def81b99
ToppCellHealthy_donor-T/NK_proliferative|Healthy_donor / disease group, cell group and cell class (v2)

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

1.05e-051971697b6bbf87e5823fa66b4cad6a7be4f777356887b59
ToppCellCOVID-19_Moderate-T/NK_proliferative|COVID-19_Moderate / disease group, cell group and cell class

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

1.09e-051981697166c000fb0e19602ffdd8bf2b2f19be2c6df96a6
ToppCellCOVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

1.09e-051981697bf0131fbca6032e1aab4aa807f8c1d3be689cb7f
ToppCellFetal_29-31_weeks-Immune|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

MPP1 IQGAP2 NLRP1 ITPR2 PTPRC ARHGAP45 FMNL1

1.09e-0519816975dff131356b8c22743bd27b2b21f86ee6e4a0a0d
ToppCellCaecum-(1)_T_cell-(18)_cycling_gd_T|Caecum / shred on region, Cell_type, and subtype

EME1 BCAN CHEK1 MELK NCAPG ASPM HELLS

1.09e-05198169764278d8831c81874937e76b561c53928dfc437c5
ToppCellmedial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

1.09e-05198169764a2bcf5a9ba66a4fe08fbde33f1886c136cde8f
ToppCellmedial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

1.09e-051981697fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8
ToppCellnormal_Lymph_Node-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

1.09e-05198169747d572b9db2843aeb2079f33a852babf67270be4
ToppCelldistal-Hematologic-Proliferating_Macrophage-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

1.09e-0519816978afeb1f9bc9d8551482c8fefe4c5f88d9cd13ee2
ToppCelldistal-Hematologic-Proliferating_Macrophage-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

1.09e-0519816972b0716e900bce54ad1825d6dcdaf4ebf31f355c4
ToppCellTracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

KRT5 KRT6A CIT MELK NCAPG ASPM HELLS

1.09e-051981697f088badb90c6c2d916195f5649eda102119c9ac6
ToppCellCaecum-T_cell-cycling_gd_T|Caecum / Region, Cell class and subclass

EME1 BCAN CHEK1 MELK NCAPG ASPM HELLS

1.09e-0519816975b719b67f8384863077070e1eb7e04a320e6dab4
ToppCell343B-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

CHEK1 CIT MELK PARP1 NCAPG ASPM HELLS

1.09e-051981697281fc2536cdc4c717b30de156e563c0e4baba99d
ToppCellmedial-Hematologic-Proliferating_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

1.09e-051981697da6963184c32761c896a9b91a5321ad84b583736
ToppCellmild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SMG1 ARGLU1 USP24 MACF1 ANKRD12 UTRN ZNF292

1.12e-051991697f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCellLeuk-UTI-Lymphocyte-T_NK-T_NK_proliferative|Leuk-UTI / Disease, Lineage and Cell Type

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

1.12e-05199169787113d398585076ece86b9098781e817f8ca241b
ToppCell(2)_B_cell-(24)_B_cell_cycling|(2)_B_cell / shred on Cell_type and subtype

EME1 TACC2 CIT MELK NCAPG ASPM HELLS

1.12e-051991697d5a9a8a71c4de8cbcef947943f60838731bc640b
ToppCellBiopsy_Control_(H.)-Epithelial-Proliferating_Epithelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type

KRT6A EME1 CHEK1 MELK NCAPG ASPM HELLS

1.12e-0519916974fcf5bec207e4384fd73c5e8801a7e414e3ee7b0
ToppCellHealthy_donor-T/NK_proliferative|World / disease group, cell group and cell class (v2)

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

1.12e-0519916971311dfd74b991f48b047a439f04f9bf7dfaa0e7a
ToppCellBronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

1.12e-0519916971d5a3366474c17e3df0ba5cf11b586655529e9bd
ToppCellILEUM-non-inflamed-(1)_T_cell-(1)_Highly_activated_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

1.12e-051991697f9bf94ab6b5b134f5b98a65340843b147941ab58
ToppCellMild-T/NK_proliferative|Mild / Disease group and Cell class

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

1.12e-05199169764a5c91243ee999ea21ffddd450d3e5fdbf6470b
ToppCellnormal_Lymph_Node-T/NK_cells-Undetermined|normal_Lymph_Node / Location, Cell class and cell subclass

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

1.12e-051991697cefcfe639a3396bccf2354ca605a1e18b964fbf2
ToppCelldistal-Hematologic-Proliferating_Macrophage|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

1.16e-0520016973835a8a9739b8cd5bf19c40765ef76907ac1ad38
ToppCelldistal-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

1.16e-0520016970cd3b01fb7f579e5abf000adb8ec8adc7cd779c4
ToppCellControl-Control-Lymphocyte-T/NK-T/NK_proliferative|Control / Disease, condition lineage and cell class

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

1.16e-0520016976cf63dd57f6bc0c42e7182322dd24ff9afbe9186
ToppCellBiopsy_IPF-Epithelial-Proliferating_Epithelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type

KRT6A EME1 CHEK1 MELK NCAPG ASPM HELLS

1.16e-05200169763c5402f050fdb12abab3c8b7f33d4914ae26b9b
ToppCellTransverse-Dendritic_cell-cycling_DCs|Dendritic_cell / Region, Cell class and subclass

CCDC14 CHEK1 CIT MELK NCAPG ASPM FUCA2

1.16e-052001697617a6a42f7b31eb3c45bdceaf55a591b6de7f154
ToppCellmild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SMG1 ARGLU1 PTPRC MACF1 ANKRD12 UTRN ZNF292

1.16e-05200169712f1685ce8f218433068e090c9d839cd5a1910bf
ToppCellMS-Multiple_Sclerosis-Lymphocyte-T/NK-T/NK_proliferative|Multiple_Sclerosis / Disease, condition lineage and cell class

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

1.16e-0520016977faf1e37364203a08d2b2544979e848b41e36b1c
ToppCelldistal-Hematologic-Proliferating_Macrophage-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

1.16e-0520016979c03a8da12d29618f72c429836c1d1bd84a78b12
ToppCellBiopsy_Other_PF-Immune-Proliferating_Macrophages|Biopsy_Other_PF / Sample group, Lineage and Cell type

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

1.16e-05200169761473e8613f39a92002d5b631e6bd563735566e4
ToppCellParenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

1.16e-052001697af3dc76b4507bf4edd265169f5dfbbb8a19eb394
ToppCelldistal-3-Hematologic-Proliferating_Macrophage|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

1.16e-0520016971b65c97e8123d0572d31525d6a10bc7f16857959
ToppCellSepsis-Leuk-UTI-Lymphocyte-T/NK-T/NK_proliferative|Leuk-UTI / Disease, condition lineage and cell class

EME1 CHEK1 CIT MELK NCAPG ASPM HELLS

1.16e-052001697093e97395be23092229521cc55aaaee8befbc149
ToppCell(24)_B_cell_cycling|World / shred on Cell_type and subtype

EME1 TACC2 CIT MELK NCAPG ASPM HELLS

1.24e-052021697a7c9b6b173701348ba35fbb975e0bdd3c1f1d5fe
ToppCellPosterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

EME1 CHEK1 MELK NCAPG PTPRQ ASPM

2.63e-051531696d7635f3d4831c02a94f53afc674847d5b51453be
ToppCellPosterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

EME1 CHEK1 MELK NCAPG PTPRQ ASPM

2.63e-05153169654a941950bbb848077c7bd5726da9e4b3244bd38
ToppCellPosterior_cortex-Macroglia-POLYDENDROCYTE-P4|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

EME1 CHEK1 MELK NCAPG PTPRQ ASPM

2.63e-05153169669a8550418ba0fc908a84b3b85761abb6e8ca4c0
ComputationalNeighborhood of RBM8A

FKBP15 TMEM94 CARD10 USP19 GPR161 ANKRD12 PML

2.96e-05851137MORF_RBM8A
ComputationalNeighborhood of CASP2

FKBP15 TMEM94 CARD10 USP19 GPR161 ANKRD12 PML

1.02e-041031137MORF_CASP2
ComputationalNeighborhood of CNTN1

FKBP15 TMEM94 UBE3B USP19 GPR161 VAMP1 ANKRD12

1.37e-041081137MORF_CNTN1
ComputationalNeighborhood of PML

FKBP15 TMEM94 CARD10 USP19 ITPR2 GPR161 ANKRD12 PML

1.40e-041451138MORF_PML
ComputationalGenes in the cancer module 68.

KRT1 KRT5 KRT6A KRT6B

1.45e-04261134MODULE_68
ComputationalKeratin.

KRT1 KRT5 KRT6A KRT6B

1.45e-04261134MODULE_298
ComputationalGenes upregulated in subsets of cells of a given type within various tumors

SMG1 ARGLU1 MACF1 UTRN ZNF292

1.55e-04491135GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN
ComputationalGenes upregulated in subsets of cells of a given type within various tumors

KRT1 KRT6A KRT6B DSC2 KRT6C

1.71e-04501135GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPISEN
ComputationalGenes in the cancer module 153.

KRT1 KRT5 KRT6A KRT6B

4.21e-04341134MODULE_153
ComputationalNeighborhood of PTPN9

FKBP15 TMEM94 USP19 ANKRD12 PML

4.37e-04611135MORF_PTPN9
ComputationalIntermediate filaments and MT.

KRT5 KRT6A KRT6B HIP1 TACC2

7.23e-04681135MODULE_438
DrugSC-791

KRT1 KRT6A KRT6B KRT75 KRT6C

1.23e-1061685CID010291510
Drugplakin

KRT6A KRT6B DSC1 DSC2 ACTG2 KRT75 KRT6C MACF1 UTRN

9.66e-09821689CID000018752
DrugDIMIT

KRT5 KRT6A KRT6B ANXA7 PPP4C KRT6C FUCA2

1.80e-07561687CID000006624
Drughomocysteine thiolactone

KRT1 KRT5 KRT6A KRT6B AHCYL1 NLRP1 DARS1 KRT75 KRT6C

5.73e-071311689CID000107712
DrugCalycanthine [595-05-1]; Down 200; 11.6uM; PC3; HT_HG-U133A

KRT6B HIP1 CEP162 ACTG2 ITPR2 EVI5 GPR161 VPS13D PML CCDC40

1.96e-06195168105744_DN
DrugMethapyrilene hydrochloride [135-23-9]; Up 200; 13.4uM; HL60; HG-U133A

PRPSAP1 VILL PIK3C2B ACAN VAMP1 MACF1 ATP11A UTRN SNX1 CCDC40

2.25e-06198168101588_UP
DrugSaquinavir mesylate [149845-06-7]; Up 200; 5.2uM; MCF7; HT_HG-U133A

CEP162 BCAN RNF17 ITPR2 AP2B1 PIP VAMP1 ATP11A ARAP1 PML

2.46e-06200168106246_UP
Drugsulfur mustard

KRT1 KRT5 KRT6A KRT6B NLRP1 PARP1 KRT75 KRT6C

5.63e-061301688CID000010461
Drugclobestasol propionate

KRT6A KRT6B KRT75 KRT6C

6.32e-06171684CID000002791
Drugchrysarobin

KRT1 KRT6A KRT6B KRT75 KRT6C

7.42e-06371685CID000068111
Drugphenyl isocyanate

KRT1 KRT5 KRT6B

7.77e-0661683ctd:C025319
Drugdithranol

KRT6A KRT6B KRT75 KRT6C

8.07e-06181684CID000002202
DrugCaLam

KRT6A KRT6B KRT75 KRT6C MVP

9.68e-06391685CID004126474
DrugLY 294002; Up 200; 10uM; MCF7; HT_HG-U133A

TSNAXIP1 RO60 DBP BCL6 TXNIP VAMP1 MAPK7 MVP PML

1.03e-0518616896987_UP
DrugOlux

KRT6A KRT6B KRT75 KRT6C

1.26e-05201684CID000032797
DrugTrifluridine [70-00-8]; Down 200; 13.6uM; HL60; HT_HG-U133A

CIT ITPR2 UBE2O ASPM AKAP1 SNX1 RASAL1 PML SOS1

1.28e-0519116896136_DN
DrugClemizole hydrochloride [1163-36-6]; Up 200; 11uM; MCF7; HT_HG-U133A

KRT6B DSC2 RO60 BCAN VPS13D GYG2 AGAP2 PML CCDC40

1.57e-0519616892301_UP
Drugestradiol; Up 200; 0.01uM; PC3; HT_HG-U133A

TSNAXIP1 UBE3B GPR161 PPP2R1B ACAN VAMP1 ATP11A MAPK7 PML

1.64e-0519716895960_UP
DrugIsometheptene mucate; Down 200; 8.2uM; HL60; HT_HG-U133A

TSNAXIP1 LAMB4 HIP1 NLRP1 ITPR2 RASAL1 ARAP1 AGAP2 PML

1.64e-0519716893145_DN
DrugBetahistine mesylate [54856-23-4]; Down 200; 17.2uM; PC3; HT_HG-U133A

FKBP15 BCAN GPR161 VPS13D DLK2 MAPK7 PLEKHO1 ARAP1 PML

1.64e-0519716896611_DN
DrugCortisone [53-06-5]; Up 200; 11uM; HL60; HT_HG-U133A

KRT6B CEP162 PPP2R1B KRT75 ACAN VAMP1 GYG2 MAPK7 CCDC40

1.70e-0519816892385_UP
DrugEthambutol dihydrochloride [1070-11-7]; Down 200; 14.4uM; PC3; HG-U133A

MPP1 TSN RO60 PPP2R1B VPS13D UBE2O IPO9 GNA11 AKAP1

1.70e-0519816891900_DN
Drug(cis-) Nanophine [5072-45-7]; Up 200; 26.8uM; MCF7; HT_HG-U133A

LAMB4 RPH3A BDKRB2 ITPR2 PPP2R1B VAMP1 SMARCA1 UTRN CCDC40

1.70e-0519816894363_UP
Drug0173570-0000 [211245-44-2]; Up 200; 1uM; PC3; HT_HG-U133A

TSNAXIP1 HIP1 EVI5 GPR161 VAMP1 ARHGAP45 MVP UTRN CCDC40

1.70e-0519816897391_UP
DrugMidecamycin [35457-80-8]; Down 200; 5uM; PC3; HG-U133A

TSN TACC2 TXNIP VPS13D IPO9 AGL VAMP1 GNA11 HELLS

1.70e-0519816891943_DN
DrugMyosmine [532-12-7]; Up 200; 27.4uM; MCF7; HT_HG-U133A

ACTG2 BCAN RPH3A ITPR2 KRT75 MAPK7 AKAP1 PLXNA2 ARAP1

1.85e-0520016894759_UP
DrugTripe

DSC1 DSC2 CIRBP

2.15e-0581683CID000015115
DrugMK-6

KRT6A KRT6B KRT75 KRT6C

2.71e-05241684CID005283547
DrugBhg-(2-1)fuc

KRT6A KRT6B KRT75 KRT6C

3.21e-05251684CID005287784
DrugAC1L9LMC

KRT6A KRT6B AARS1 KRT75 KRT6C UTRN

3.48e-05831686CID000448113
Drugbetamethasone valerate

KRT6A KRT6B KRT75 KRT6C

5.10e-05281684CID000016533
Drug1-2q

KRT1 KRT5 KRT6A KRT6B BCL6 ATL1 MEN1 IPO9 KRT75 KRT6C

5.99e-0528916810CID000011820
DrugVincristine

TPRG1L CAMKK1 TDRD9 IQGAP2 YTHDC2 QRICH1 BDKRB2 EPG5 CIRBP FMNL3 TXNIP VPS13D THADA XIRP2 ASPM GPR137B MACF1 SCLT1 MVP ATP5F1C SOS1 HELLS

6.09e-05118216822ctd:D014750
Drug2-Formyl-Protoporphryn Ix

KRT6A KRT6B KRT75 KRT6C

7.70e-05311684CID011963946
DrugAGN 193109

KRT6A KRT6B KRT75 KRT6C

7.70e-05311684CID000177238
DrugAntimycin A [1397-94-0]; Down 200; 7.2uM; HL60; HG-U133A

RO60 BCAN TXNIP EVI5 NCAPG ACAN PLEKHO1 HELLS

8.04e-0518816881414_DN
DrugAC1L9MJT

KRT1 KRT5 KRT6A KRT6B ANXA7 PTPRC KRT75 KRT6C

9.31e-051921688CID000448959
Drugindomethacin, USP; Up 200; 100uM; PC3; HG-U133A

VPS13D PPP4C AGL SMARCA1 DLK2 GNA11 ANKRD12 PML

9.31e-051921688452_UP
DrugSulfamonomethoxine [1220-83-3]; Down 200; 14.2uM; HL60; HT_HG-U133A

NLRP1 ITPR2 VPS13D ATP11A MVP UTRN ARAP1 PML

1.00e-0419416882742_DN
DrugProcainamide hydrochloride [614-39-1]; Down 200; 14.8uM; PC3; HT_HG-U133A

USP24 YTHDC2 PPP2R1B AP2B1 VAMP1 AKAP1 UTRN PLXNA2

1.00e-0419416884602_DN
DrugMethoxy-8-psoralen [298-81-7]; Up 200; 18.6uM; MCF7; HT_HG-U133A

TSNAXIP1 KRT6B BCAN PPP2R1B DLK2 UTRN PLXNA2 PML

1.04e-0419516885007_UP
DrugPHA-00745360 [351320-33-7]; Down 200; 1uM; MCF7; HT_HG-U133A

KRT6B BCL6 RNF17 VAMP1 DLK2 AGAP2 DOP1B CCDC40

1.04e-0419516884384_DN
DrugNSC 59264

KRT1 NLRP1 PARP1

1.07e-04131683CID000072282
DrugTinidazole [19387-91-8]; Up 200; 16.2uM; MCF7; HT_HG-U133A

MPP1 ITPR2 EVI5 PPP2R1B KRT75 AMOT ACAN PML

1.07e-0419616884370_UP
DrugBeclomethasone dipropionate [5534-09-8]; Down 200; 7.6uM; MCF7; HT_HG-U133A

DSC2 CEP162 AKAP12 DLK2 MAPK7 PLXNA2 ARAP1 PML

1.07e-0419616884403_DN
Drug3-Acetylcoumarin [3949-36-8]; Down 200; 21.2uM; MCF7; HT_HG-U133A

KRT6B BCAN F9 RPH3A ITPR2 ATP11A MAPK7 ZNF292

1.07e-0419616885624_DN
DrugCrotamiton [483-63-6]; Up 200; 19.6uM; MCF7; HT_HG-U133A

RO60 VILL ACAN SMARCA1 ADGRL3 AGAP2 DOP1B CCDC40

1.07e-0419616885689_UP
DrugFludrocortisone acetate [514-36-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A

KRT6B DSC2 BCAN BCL6 VPS13D GYG2 PML DOP1B

1.11e-0419716882328_UP
DrugMethiazole; Up 200; 15uM; PC3; HT_HG-U133A

DSC1 CEP162 RO60 BCAN ITPR2 EVI5 VAMP1 PML

1.11e-0419716884532_UP
DrugColchicine [64-86-8]; Down 200; 10uM; MCF7; HT_HG-U133A

CEP162 YTHDC2 DBP EVI5 VPS13D VAMP1 ATP11A PML

1.11e-0419716885675_DN
DrugMethylatropine nitrate [52-88-0]; Up 200; 11uM; MCF7; HT_HG-U133A

TSNAXIP1 LAMB4 CEP162 RNF17 DLK2 UTRN AGAP2 PML

1.15e-0419816886495_UP
DrugOxytetracycline dihydrate [6153-64-6]; Up 200; 8uM; HL60; HG-U133A

BCL6 TRRAP ITPR2 ACAN MACF1 ARAP1 ZNF292 SOS1

1.15e-0419816881553_UP
DrugCaptopril [62571-86-2]; Up 200; 17.2uM; PC3; HG-U133A

NLRP1 SMC5 AKAP12 EVI5 VPS13D THADA DHX29 UTRN

1.15e-0419816881907_UP
DrugKetanserin tartrate hydrate [83846-83-7]; Up 200; 7uM; HL60; HG-U133A

NLRP1 BCAN SMC5 THADA PIK3C2B ACAN PLEKHO1 UTRN

1.15e-0419816881593_UP
DrugMifepristone [84371-65-3]; Up 200; 9.4uM; PC3; HT_HG-U133A

LAMB4 DCHS2 BCAN MVP SNX1 PLXNA2 PML SOS1

1.15e-0419816885827_UP
DrugDioxybenzone [131-53-3]; Down 200; 16.4uM; MCF7; HT_HG-U133A

DSC2 RO60 BCAN EVI5 VPS13D VAMP1 GNA11 ATP11A

1.15e-0419816886478_DN
Drug3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol

RRM2B EXOC8 EPG5 CIRBP PPP2R1B BRD8 NCAPG ANKRD12 AKAP1 AGAP2

1.19e-0431416810ctd:C572491
DrugDorzolamide hydrochloride [130693-82-2]; Up 200; 11uM; MCF7; HT_HG-U133A

LAMB4 DBP RNF17 BDKRB2 ITPR2 PIP GYG2 ARAP1

1.19e-0419916883565_UP
DrugDantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A

BCAN BCL6 RNF17 ACAN GYG2 PLXNA2 AGAP2 PML

1.19e-0419916882329_UP
DrugPrimidone [125-33-7]; Up 200; 18.4uM; MCF7; HT_HG-U133A

TSNAXIP1 KRT6B RNF17 RPH3A PPP2R1B VAMP1 ATP11A ARAP1

1.19e-0419916883402_UP
Drugclozapine; Up 200; 10uM; HL60; HT_HG-U133A

LAMB4 KRT6B NLRP1 CARD10 BCL6 RNF17 KRT75 PML

1.19e-0419916886188_UP
Drughaloperidol; Up 200; 10uM; MCF7; HT_HG-U133A

TSNAXIP1 DCHS2 VAMP1 GYG2 ANKRD12 AKAP1 PLXNA2 PML

1.19e-0419916885604_UP
DrugMephenesin [59-47-2]; Up 200; 22uM; PC3; HT_HG-U133A

KRT6B UBE3B GPR161 PIP ARHGAP45 PLEKHO1 PML DOP1B

1.19e-0419916887374_UP
DrugAC1L1JLU

KRT6A KRT6B KRT75 KRT6C ACAN PML

1.23e-041041686CID000005098
DrugBDE-47

LRAT NLRP1 AGAP2

1.35e-04141683CID000095170
Drug3-deoxy-3-fluoro-D-glucose

KRT1 KRT5 HK1

1.68e-04151683CID000450201
DiseaseMixed anxiety and depressive disorder

FMR1 PLXNA2

3.15e-0521662C0338908
DiseasePachyonychia congenita syndrome

KRT6A KRT6B

1.87e-0441662cv:C0265334
DiseasePachyonychia Congenita, Jadassohn Lewandowsky Type

KRT6A KRT6B

1.87e-0441662C1706595
Diseasepachyonychia congenita (is_implicated_in)

KRT6A KRT6B

1.87e-0441662DOID:0050449 (is_implicated_in)
DiseasePachyonychia Congenita, Type 2 (disorder)

KRT6A KRT6B

1.87e-0441662C1721007
Diseaseobesity (implicated_via_orthology)

DCHS2 SDK2 HK1 EIF6 ITPR2 THADA GNA11

2.25e-042151667DOID:9970 (implicated_via_orthology)
DiseaseIntellectual Disability

HK1 FMR1 TMEM94 RRM2B QRICH1 TRRAP ATL1 PARP1 MACF1 ZNF292

2.34e-0444716610C3714756
Diseasearrhythmogenic right ventricular cardiomyopathy (implicated_via_orthology)

DSC1 DSC2

3.11e-0451662DOID:0050431 (implicated_via_orthology)
DiseasePachyonychia Congenita

KRT6A KRT6B

3.11e-0451662C0265334
DiseaseVitamin A Deficiency

LRAT PARP1

3.11e-0451662C0042842
Diseasedesmocollin-2 measurement

DSC1 DSC2

3.11e-0451662EFO_0021936
DiseaseHbA1c measurement

HK1 CARMIL1 RPH3A HMG20A GPR161 THADA MACF1 ATP11A ARHGAP45 PLEKHO1 ARAP1 SOS1

4.62e-0467516612EFO_0004541
DiseaseAbnormal muscle tone

HK1 ZNF292

4.65e-0461662C0852413
Diseasecolorectal cancer (biomarker_via_orthology)

HK1 TXNIP

4.65e-0461662DOID:9256 (biomarker_via_orthology)
Diseasepreterm premature rupture of the membranes, spontaneous preterm birth

FSTL5 KSR2 FMNL3

5.17e-04281663EFO_0006917, MONDO_0012511
Diseasepursuit maintenance gain measurement

SDK2 CARMIL1 KSR2 EPG5 PLXNA2

6.72e-041231665EFO_0008433
Diseasemicrocephaly (implicated_via_orthology)

AARS1 CIT ASPM

7.69e-04321663DOID:10907 (implicated_via_orthology)
Diseasealcohol dependence, risky sexual behaviour measurement

FSTL5 HMG20A

8.61e-0481662EFO_0007877, MONDO_0007079
DiseaseCardiomyopathies

DSC2 BDKRB2 EPG5 PARP1 SOS1

8.62e-041301665C0878544
Diseaselate-onset Alzheimers disease

IQGAP2 TMEM94 KSR2 HMG20A SLMAP DNAH6 ATP5F1C

1.38e-032921667EFO_1001870
Diseaseresponse to paliperidone, schizophrenia symptom severity measurement

IQGAP2 FSTL5 RNF135 USP24 SMC5 EPG5

1.44e-032161666EFO_0007925, EFO_0007927
Diseaseinterleukin-6 measurement, response to stimulus

CARMIL1 FSTL5

1.67e-03111662EFO_0004810, GO_0050896
Diseasehigh grade glioma (is_marker_for)

BCAN ASPM HELLS

1.71e-03421663DOID:3070 (is_marker_for)
DiseaseCongenital Heart Defects

TMEM94 TRRAP GNA11

1.96e-03441663C0018798
Disease1-stearoyl-2-linoleoyl-GPI (18:0/18:2) measurement

MYO5B TMC4

2.36e-03131662EFO_0800413
Diseasecomplement factor H-related protein 4 measurement

KSR2 PTAR1 ASPM

2.66e-03491663EFO_0600091
Diseasetrimethylamine-N-oxide measurement

ITPR2 TAS1R2

2.74e-03141662EFO_0010541
Diseasecaudate volume change measurement

AARS1 KSR2

2.74e-03141662EFO_0021491
Diseaseurate measurement, bone density

MTHFD1L CARMIL1 FSTL5 QRICH1 AKAP12 ATL1 HMG20A ITPR2 UTRN RASAL1

2.75e-0361916610EFO_0003923, EFO_0004531
Diseasehigh grade glioma (biomarker_via_orthology)

BCAN BDKRB2

3.15e-03151662DOID:3070 (biomarker_via_orthology)
DiseaseDupuytren Contracture

DCHS2 TACC2 ATL1 ACAN

3.29e-031081664EFO_0004229
DiseaseKeratoderma, Palmoplantar

KRT1 KRT6C

3.58e-03161662C4551675
Diseasepancreatic ductal carcinoma (is_implicated_in)

HEATR1 MEN1

3.58e-03161662DOID:3587 (is_implicated_in)
Diseasesphingomyelin 14:0 measurement

THADA GPR137B

4.05e-03171662EFO_0010390
DiseaseIschemic stroke, venous thromboembolism, stroke, Abnormal thrombosis, deep vein thrombosis, pulmonary embolism

LRAT SLC44A2

4.05e-03171662EFO_0000712, EFO_0003827, EFO_0003907, EFO_0004286, HP_0001977, HP_0002140
Diseaseplatelet-to-lymphocyte ratio

PRPSAP1 IQGAP2 CARMIL1 TMC4 PTPRC AP2B1 ARHGAP45

4.61e-033631667EFO_0008446
Diseaseperipheral arterial disease, traffic air pollution measurement

MTHFD1L AKAP12 ITPR2 MACF1 UTRN

4.92e-031941665EFO_0004265, EFO_0007908
DiseaseAbnormality of refraction

SMG1 TDRD9 MYO5B MTHFD1L KSR2 ZBTB4 DCTN1 ITPR2 UTRN ADGRL3

4.94e-0367316610HP_0000539
Diseasesphingomyelin measurement

KRT1 KRT5 KRT6A NLRP1 RPH3A KRT6C

5.02e-032781666EFO_0010118
Diseasefreckles

EIF6 AKAP1

5.59e-03201662EFO_0003963
Diseasepolymyositis

SDK2 UBE3B

5.59e-03201662EFO_0003063

Protein segments in the cluster

PeptideGeneStartEntry
VEETVVRDKAVESLR

PPP2R1B

111

P30154
RRTNVDEDFIKIIVL

EPG5

786

Q9HCE0
EIQTERRATVLVLVV

BDKRB2

261

P30411
RVKVDVLRQIRSDFV

AKAP1

801

Q92667
VIHVEVTEKNVREVR

CARD10

941

Q9BWT7
RLQKVETEIQRVSEA

AMOT

461

Q4VCS5
VVQEAIVVIRDIFRK

AP2B1

406

P63010
VREAQKRVEAAQETV

DCTN1

496

Q14203
AVNRVTEEAVAVKIV

CHEK1

26

O14757
TVEDVIVRKLTAERV

BRD8

91

Q9H0E9
IVKVTFEELRQEVAL

AACS

126

Q86V21
ERRTQEVLQAVAEKV

AKAP12

1036

Q02952
ESIERLRVIANEIEK

APOL4

121

Q9BPW4
EIIVTREALNTKEAV

BTBD6

286

Q96KE9
IEEETARRVEELVAK

ARGLU1

126

Q9NWB6
IVRENTDNIKLEVAR

ADGRL3

676

Q9HAR2
FVTTAEREIVRDIKE

ACTG2

201

P63267
DRVFQEVAQKVVTLR

AGAP2

556

Q99490
RIVVTRSEIDLVQIK

ANXA7

441

P20073
REKLIVSNEQEVLRV

ANKRD12

1921

Q6UB98
RVRVIKSEDDVLVVC

DHX29

411

Q7Z478
RVREKALEDVVVLNV

DENND1C

276

Q8IV53
RDSIVREVIQNSKEV

MTHFD1L

71

Q6UB35
ITRIKIELEEALVNV

CCDC14

591

Q49A88
RITESRQVVELAVKE

CIT

1081

O14578
VEILRVTVEDKDLVN

DSC2

371

Q02487
VRVAITEHTEVREIK

ASPM

586

Q8IZT6
LVKVDDEVVARTATV

RASAL1

31

O95294
RILVIREIQEAIAVA

QRICH1

756

Q2TAL8
VLRVTVADIEKELAE

QRICH2

1131

Q9H0J4
IKVVDRDSEEAEIIR

PARP1

801

P09874
ELVIDVIVNTKNDRI

ITPR2

1756

Q14571
RRRAKQVVSVVQDEE

NIBAN2

616

Q96TA1
EEETRVVFRQIVSAV

MELK

106

Q14680
VRQKVRIVSREAEAA

MEN1

456

O00255
IIAARKQSVEEIVRD

PGM5

406

Q15124
REAEVLVARGVRVKV

BCAN

86

Q96GW7
ALTRERIKEAIVAEI

MAPK7

371

Q13164
RLVTANTIDQKIVER

HELLS

721

Q9NRZ9
LRKQQEDVSVVRRTE

KIAA0100

1896

Q14667
IQRVRAEEREQIKTL

KRT6C

156

P48668
VLEVLARAIRQEKEI

nan

671

O00370
EDTKVTALRQIQEVI

ARHGAP45

481

Q92619
VDRIVDKEIDIRQVK

MAP10

656

Q9P2G4
KVLEHVVRVNARVRI

MAGEA4

286

P43358
DLARVRRFQVVEVTK

M1AP

166

Q8TC57
IQRVRAEEREQIKTL

KRT6A

156

P02538
RTAVEKLEVDVIQER

HMG20A

261

Q9NP66
KLEVDVIQERSRNTV

HMG20A

266

Q9NP66
VVEVTEEEVKNSVRL

CAMKK1

426

Q8N5S9
NRDVQVKSVEVLIRI

DOP1B

1341

Q9Y3R5
QVRRLVEEVTDDKTL

HDDC3

81

Q8N4P3
IQRVRTEEREQIKTL

KRT5

161

P13647
FRIVDVRKEVLEEIS

KSR2

96

Q6VAB6
ARVVLQDEDITTKIE

PLXNA2

1561

O75051
VRNSKIEISELNRVI

KRT1

391

P04264
IQRVRAEEREQIKTL

KRT6B

156

P04259
TVIVGVVRRVDREEL

PDE8A

156

O60658
REQLIARVTSVEVVL

NLRP1

1386

Q9C000
LRRAEQEVISLQEKV

EVI5

601

O60447
ETEHTEQKRNVIRII

F9

286

P00740
TDSILVFEVEVRRVK

FKBP15

276

Q5T1M5
VIVKVASIRVDTVED

LRAT

101

O95237
KDQERVAEVSRVRVE

LRRC45

561

Q96CN5
AKVEERVRQLTEVLV

EXOC8

381

Q8IYI6
IKRREEFDLDVVAVV

HK1

641

P19367
LAIETEAELQRVQKV

MVP

751

Q14764
LKTVDVIVRSIQDAE

MACF1

1156

Q9UPN3
EKEVVLLVATEGRVR

ACAN

81

P16112
LDRVLIVDVQSQKVV

FSTL5

521

Q8N475
IVVKDVSIRVEDILT

PTPRQ

241

Q9UMZ3
LAVRENREKVVEALT

PIK3C2B

576

O00750
LDREVQEAVELKVVA

DCHS2

621

Q6V1P9
EEILADVLKVEVFRQ

EIF6

126

P56537
RVILSKVFDEVIEVN

GYG2

81

O15488
IVKELEVAIRNRTDL

FUCA2

161

Q9BTY2
KAAQVIRLAEVTERL

DNAH6

346

Q9C0G6
EIVDKSGVVRVRIEA

FMR1

306

Q06787
ILLSEAVRDKEVVAV

ATL1

56

Q8WXF7
RRVQESTKVLRELEI

FMNL3

101

Q8IVF7
LLIREVDVEKVTTFE

GNA11

111

P29992
VVKKAETERIRAEIE

CCDC40

421

Q4G0X9
DRLTEFVTVLQKRVE

CCDC13

561

Q8IYE1
SLVVSEVREEILQKE

CEP162

1276

Q5TB80
LTDVVIVVSREQFRA

BCL6

31

P41182
KRRVQESTQVLRELE

FMNL1

111

O95466
RREQQEIKVVLSARE

DSC1

101

Q08554
VQEVRAAAEEQIKVL

IPO9

36

Q96P70
TVVIVEEDAQRTGRK

GPR161

226

Q8N6U8
QTRELVDRAVNRIKE

KHDC4

166

Q7Z7F0
RILEDQVVAIKNEIV

LAMB4

1736

A4D0S4
ETRVEIKESVRGQDI

PRPSAP1

46

Q14558
NRTRQAVITKELIEI

ATP5F1C

276

P36542
RNIIRVAVLDKVTDF

SLC44A2

586

Q8IWA5
EKENALLRQEVVAVR

DBP

291

Q10586
EVTRVVDEQLKALLE

CARMIL1

766

Q5VZK9
VKRSIITVEELTEIE

CARMIL1

891

Q5VZK9
IEVSRNVEEIVVKII

HEATR1

1366

Q9H583
VRKVRLIQFEKVTEE

MPP1

66

Q00013
RQPEREEKIVVVDIS

EME1

36

Q96AY2
LLRISVKEVVRRQEA

DLK2

286

Q6UY11
AAVVEVEKLTRFRQR

SDK2

346

Q58EX2
ERKVIVSVRVAINDT

GPR137B

186

O60478
RIVTEVIEVREATEV

GARIN2

261

Q8N9W8
DLLETVRVREQAITK

UTRN

651

P46939
ELQRVAVEKSITEVA

RNF135

121

Q8IUD6
VEEVVDIIRVNVDKV

VAMP1

41

P23763
LNDVEFREVTELIKV

GTF2A2

76

P52657
VKTVEFTRLRIQEER

THADA

1896

Q6YHU6
TDEEKEIINRVIARA

RPH3A

51

Q9Y2J0
VIKIRSVASREEVAI

HARS2

476

P49590
VVQIKEETRLVSVID

RSPH9

131

Q9H1X1
NTVEERIVERAEIKL

SMARCA1

626

P28370
EEVAVLVQRVVKDIT

PTAR1

6

Q7Z6K3
EDVVEVNILRAAINK

TDRD9

1281

Q8NDG6
RVVKLNEVIRQVDVV

AHCYL1

356

O43865
ELEVARLREEVVTKI

IQGAP2

801

Q13576
TEAIILVQKAERARQ

IQCA1L

161

A6NCM1
EELIRERVRQVVAHV

PML

276

P29590
VERELEKVDAVRLIN

PPWD1

346

Q96BP3
LIRQVERLKQEAVTV

SMG1

2721

Q96Q15
VLIVASKDLQREIVE

HIP1

836

O00291
VDVEKQIEAFRSRLI

SIMC1

816

Q8NDZ2
IQKLEARVRELESEV

MYH4

1816

Q9Y623
VRVRDLTIQKADEVV

DARS1

46

P14868
DVVKEVVRRNREAGI

SI

366

P14410
IRAVLKEVEQLLTRE

IQANK1

151

A8MXQ7
RTVQIAAVVDVIREL

PIP

106

P12273
AVEKVKRTRDELEVI

RO60

231

P10155
EERVAVVSRIIEILQ

SOS1

846

Q07889
ITRAKNRILDEVTVE

PLEKHO1

131

Q53GL0
ADVQRDVKIELILAV

RANBP6

91

O60518
KVVDIDFVLQARTIR

ABHD1

271

Q96SE0
VVVFSVDEEELRKQR

ARAP1

1136

Q96P48
QISEVVVVKDRETQR

CIRBP

31

Q14011
IIIDDNKRTQIVTEI

NCAPG

451

Q9BPX3
VIEGKVDQIRARVER

ATP11A

586

P98196
VREIIVDAVKIEQEF

RRM2B

251

Q7LG56
QKQTIEERERVIEVV

RNF17

176

Q9BXT8
VDAQEEIRKVEKRAT

XIRP2

3081

A4UGR9
SLVDEEVKVAVIRDT

TTLL11

556

Q8NHH1
RQSAEEVIVKLRVGV

USP19

121

O94966
ELAKERVVVLEVQQR

USP19

766

O94966
QVITRTQEEKLEHVR

TRIM55

231

Q9BYV6
VVEVKVSDSRRIGVI

VSIG8

251

P0DPA2
TEEAIAKGIRRIVAV

AARS1

741

P49588
DFERISTVVRKEVIR

SNX1

466

Q13596
VVTNEIVKLHEIRVR

TMEM94

1321

Q12767
ESLRRVLQEKIEVVR

SLMAP

256

Q14BN4
KVELEETVVRRQAAV

TMC4

321

Q7Z404
IEQAVEEIRVVVRPV

TPRG1L

71

Q5T0D9
KFRVVVEEVQVVELK

UBE2O

291

Q9C0C9
VRKEEETAVAIQTIE

ZNF292

2561

O60281
VRIGEEAIVKRRISE

ZBTB4

606

Q9P1Z0
LQIARAEIITKEREV

TACC2

2751

O95359
RVAVAKVEELTNVTE

SCLT1

236

Q96NL6
SEERQRLVTIVDKLQ

TAS1R2

251

Q8TE23
VVTVISRKNEETVLE

VILL

566

O15195
EERLVQKERERAAVV

UBE3B

21

Q7Z3V4
IDEEVKIAVNIALER

YTHDC2

41

Q9H6S0
VREVRVAVATILEKT

USP24

2231

Q9UPU5
VRIITTAVDKRVNDL

UCKL1

501

Q9NWZ5
KEEAVVEILQTALER

TSNAXIP1

626

Q2TAA8
KVAGRVIVEVCEVTR

TXNIP

26

Q9H3M7
VIVEVCEVTRVKAVR

TXNIP

31

Q9H3M7
VGTEKTRERIERVIQ

SMC5

591

Q8IY18
KAREILVEESNVQRV

PPP4C

31

P60510
TEEVVDIFQVVKALR

PTPRC

1191

P08575
EQRRLAVDLSEVVIK

TRRAP

2001

Q9Y4A5
AELTKVEEEIVTLRQ

TPD52L2

51

O43399
VEEEIVTLRQVLAAK

TPD52L2

56

O43399
REEIRKVVQSLEQTA

TSN

21

Q15631
VTRIVENIELKIQDV

VPS13D

141

Q5THJ4
KIEEVVLEARTIERN

AGL

771

P35573
TIQRVRAEEREQIKT

KRT75

141

O95678
VRKEEVLILRTQIVS

MYO5B

1256

Q9ULV0